Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023430	s-kisshie	— (—)	3108	3199	100.00%	Distribution not available
3023430	s-kisshie	u/ml (u/ml)	2710	2886	2.53%
3023430	kissa	— (—)	612	643	100.00%	Distribution not available
3023430	kissa	u/ml (u/ml)	146	150	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma

1865

1993

5.05

307.65

1.1

1.0

5.78

5.06

u/ml

0.53

1043

647

Allergic asthma (mode)

919

1279

7.46

307.65

1.1

1.0

8.09

5.47

u/ml

2.05

635

441

Asthma, excluding more controls

1847

1975

5.02

307.65

1.1

1.0

5.81

5.12

u/ml

0.50

1035

639

Asthma and allergy

681

807

9.09

307.65

1.1

1.0

9.22

5.79

u/ml

2.04

479

282

Asthma, hospital admission 2, infections

1160

3036

3.84

307.65

1.1

1.0

6.61

4.71

u/ml

2.05

673

1128

Asthma, including avohilmo

2741

3538

4.47

307.65

1.1

1.0

6.29

4.09

u/ml

4.58

1425

1260

Asthma (only as main-diagnosis), excluding more controls

1793

1975

5.36

307.65

1.1

1.0

5.92

5.12

u/ml

0.59

1013

639

Asthma (only as main-diagnosis)

1801

1993

5.40

307.65

1.1

1.0

5.89

5.06

u/ml

0.63

1018

647

Vasomotor and allergic rhinitis

1453

2330

6.49

307.65

1.1

1.0

7.09

5.65

u/ml

1.21

859

867

1005

2558

4.02

307.65

1.1

1.0

6.97

5.04

u/ml

1.74

584

974

Pollen allergy

1082

1627

7.28

307.65

1.1

6.72

5.48

u/ml

0.80

661

658

Asthma/COPD (KELA code 203)

1996

3796

3.69

307.65

1.1

1.0

6.87

4.30

u/ml

4.61

1087

1359

Asthma-related infections

1160

3036

3.84

307.65

1.1

1.0

6.61

4.71

u/ml

2.05

673

1128

Asthma, hospital admissions , main diagnosis only

1905

4374

3.95

307.65

1.1

1.0

6.44

4.66

u/ml

2.59

1095

1618

Asthma and allergy, excluding more controls

682

819

8.97

307.65

1.1

1.0

9.20

5.71

u/ml

2.15

480

294

Allergic asthma (mode), excluding more controls

919

1279

7.46

307.65

1.1

1.0

8.09

5.48

u/ml

2.03

635

440

Chronic lower respiratory diseases

2511

3816

3.58

307.65

1.1

1.0

6.36

4.38

u/ml

3.61

1337

1364

Asthma (mode)

1874

1998

5.17

307.65

1.1

1.0

5.76

5.04

u/ml

0.54

1054

650

Allergic rhinitis

1379

2331

6.29

307.65

1.1

1.0

7.12

5.41

u/ml

1.58

836

888

Asthma (diagnoses ohter than nonallergic)

1964

4265

3.93

307.65

1.1

1.0

6.48

4.66

u/ml

2.73

1134

1557

Asthma, unspecified (mode)

893

1742

3.94

275.34

1.1

1.0

4.12

4.97

u/ml

0.65

413

565

Asthma, unspecified (mode), excluding more controls

889

1731

3.92

271.87

1.1

1.0

4.14

5.02

u/ml

0.68

411

559

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1194

3864

3.08

269.91

1.1

4.93

5.27

u/ml

0.25

670

1494

Allergic conjunctivitis

1234

4103

3.01

267.18

1.1

5.06

5.43

u/ml

0.28

698

1594

Conjunctivitis

1452

4596

2.69

248.47

1.1

5.24

5.80

u/ml

0.51

792

1827

Chronic sinusitis

751

1978

3.89

246.85

1.1

1.0

3.35

4.92

u/ml

1.67

342

691

Other diseases of upper respiratory tract

1555

3051

2.69

234.55

1.1

1.0

5.57

5.40

u/ml

0.09

767

1121

Atopic dermatitis

1304

3963

2.76

232.34

1.1

1.0

8.47

4.45

u/ml

7.04

727

1533

Disorders of conjunctiva

1481

4700

2.58

230.43

1.1

5.17

5.75

u/ml

0.54

804

1868

Chronic rhinitis, nasopharyngitis and pharyngitis

614

1494

4.23

225.96

1.1

1.0

3.40

5.15

u/ml

1.54

294

533

Desensitization to allergens

341

511

7.61

222.09

1.1

7.14

5.43

u/ml

0.69

228

224

Obesity related asthma

584

1432

4.19

212.61

1.1

1.0

5.67

3.70

u/ml

1.07

303

460

Suggestive for eosinophilic asthma

216

232

9.80

182.61

1.2

1.0

3.32

4.26

u/ml

0.26

144

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

741

2284

3.21

181.32

1.1

1.0

3.71

4.60

u/ml

0.73

345

798

Nasal polyp

320

551

5.98

177.31

1.1

1.0

3.28

3.15

u/ml

0.06

184

188

Atopic dermatitis, strict definition with reimbursement

786

2596

3.02

170.12

1.1

9.88

5.06

u/ml

5.94

518

1049

Dermatitis and eczema

1605

4590

2.19

165.53

1.1

1.0

7.42

4.12

u/ml

6.07

834

1777

Other pulmonary diagnosis

1048

2025

2.62

149.27

1.1

1.0

4.48

5.03

u/ml

0.36

485

662

COPD differential diagnosis

1027

1999

2.60

144.25

1.1

1.0

4.42

5.15

u/ml

0.51

475

651

ILD differential diagnosis

1026

1998

2.60

143.97

1.1

1.0

4.43

5.04

u/ml

0.41

474

650

Excluding asthma or asthma-COPD overlap

1026

2025

2.57

140.30

1.1

1.0

4.43

5.03

u/ml

0.40

473

662

Oral corticosteroids

1462

4187

2.09

133.17

1.1

1.0

5.54

4.73

u/ml

0.79

730

1620

Undetermined asthma

237

410

5.96

130.76

1.1

1.0

3.05

4.79

u/ml

0.72

114

122

Undetermined asthma, excluding more controls

237

412

5.93

130.10

1.1

1.0

3.05

4.83

u/ml

0.74

114

121

ILD medications: prednisolone, methylprednisolone, prednisone

1524

4224

2.04

127.62

1.1

1.0

5.58

5.08

u/ml

0.41

752

1677

Cough

607

1990

2.94

126.91

1.1

5.74

5.66

u/ml

0.02

273

823

Atopic dermatitis, strict definition

736

2827

2.63

123.14

1.1

10.44

5.34

u/ml

6.16

486

1181

Biological medicines for asthma

117

14.46

121.79

1.3

1.1

6.37

5.35

u/ml

0.18

Childhood asthma (age<16)

411

886

3.80

120.80

1.1

1.0

10.15

6.29

u/ml

1.97

280

334

Childhood asthma (age<16), excluding more controls

411

886

3.80

120.70

1.1

1.0

10.15

6.31

u/ml

1.95

280

333

Asthma, hospital admissions 3, pneumonia

430

1279

3.41

117.49

1.1

1.0

4.53

4.72

u/ml

0.09

266

452

Asthma-related pneumonia or sepsis

430

1279

3.41

117.49

1.1

1.0

4.53

4.72

u/ml

0.09

266

452

Asthma-related pneumonia

428

1276

3.40

116.53

1.1

1.0

4.53

4.75

u/ml

0.10

266

449

FESS (DNB20)

278

631

4.59

112.89

1.1

2.69

4.05

u/ml

0.84

144

243

Ethmoidectomy

281

646

4.52

112.23

1.1

2.66

4.02

u/ml

0.87

146

246

Diseases of the respiratory system

763

1482

2.61

107.83

1.1

1.0

4.67

5.01

u/ml

0.15

334

479

ILD medications

1537

4437

1.90

104.20

1.1

1.0

5.53

5.32

u/ml

0.15

751

1810

Deviated nasal septum

378

1135

3.38

102.04

1.1

1.0

3.99

4.12

u/ml

0.05

178

380

Abnormalities of breathing

1297

3859

1.97

100.37

1.1

5.89

5.54

u/ml

0.17

579

1618

Inflammatory bowel disease treatment related agents

1508

4597

1.85

95.98

1.1

5.59

5.03

u/ml

0.50

744

1842

Symptoms and signs involving the circulatory and respiratory systems

1405

3886

1.83

83.66

1.1

5.67

5.54

u/ml

0.06

638

1630

First line medication for Crohn's disease

1453

4409

1.80

83.45

1.1

1.0

5.92

5.21

u/ml

0.64

704

1806

Chronic diseases of tonsils and adenoids

958

3007

2.03

82.51

1.1

1.0

5.57

5.47

u/ml

0.04

423

1106

Insomnia

1157

4804

1.77

67.73

1.1

5.38

5.20

u/ml

0.10

465

2028

Acute upper respiratory infections

1215

4304

1.75

66.47

1.1

5.60

5.21

u/ml

0.21

556

1773

Childhood allergy (age < 16)

454

1589

2.44

62.49

1.1

12.00

6.38

u/ml

3.93

309

728

Sleep disorders

1142

4815

1.73

61.49

1.1

5.09

5.21

u/ml

0.06

465

2048

Adverse effects, not elsewhere classified

364

1431

2.61

61.09

1.1

6.35

5.82

u/ml

0.19

228

611

Dermatitis due to ingested food

159

382

4.32

57.22

1.1

12.50

8.47

u/ml

0.96

116

188

Acute upper respiratory infections of multiple and unspecified sites

972

4110

1.77

56.99

1.1

6.50

5.27

u/ml

0.73

440

1694

Sleep apnoea, including avohilmo

1048

3765

1.74

55.80

1.1

3.48

4.32

u/ml

1.03

435

1525

Acute sinusitis

727

3598

1.89

55.03

1.1

4.38

5.04

u/ml

0.48

323

1471

Urticaria

486

2267

2.18

54.97

1.1

4.68

5.73

u/ml

0.54

262

964

Dyspnoea

954

4084

1.74

52.93

1.1

5.25

4.82

u/ml

0.20

431

1668

Behavioural syndromes associated with physiological disturbances and physical factors

1140

4928

1.65

52.01

1.1

5.13

5.34

u/ml

0.13

485

2121

Urticaria and erythema

533

2638

2.05

51.44

1.1

5.30

5.63

u/ml

0.13

285

1119

Non-allergic asthma (mode)

205

647

3.18

50.50

1.1

1.0

4.03

5.30

u/ml

0.32

220

Sleep disorders (combined)

1292

4231

1.61

50.39

1.1

4.62

5.41

u/ml

0.71

547

1829

Non-allergic asthma (mode), excluding more controls

205

650

3.17

50.11

1.1

1.0

4.03

5.32

u/ml

0.32

223

Chronic laryngitis and laryngotracheitis

148

385

3.91

50.01

1.1

1.0

2.90

2.94

u/ml

0.01

124

Bronchitis

1228

4858

1.60

48.50

1.1

5.75

5.01

u/ml

0.49

565

2000

Other medical care

416

1718

2.20

47.71

1.1

6.68

4.46

u/ml

1.44

249

677

1229

3979

1.61

46.96

1.1

1.0

5.57

5.12

u/ml

0.24

555

1596

Personal history of allergy to drugs, medicaments and biological substances

10.61

45.98

1.3

1.1

3.23

4.65

u/ml

0.25

Any reimbursement code in KELA

950

2878

1.67

41.85

1.1

1.0

7.70

4.41

u/ml

2.78

484

1059

Diseases of the eye and adnexa

1116

3567

1.58

39.49

1.1

6.23

5.78

u/ml

0.21

548

1415

Diseases of the skin and subcutaneous tissue

1121

3597

1.57

39.16

1.1

1.0

6.75

3.97

u/ml

3.22

553

1359

Other and unspecified effects of external causes

428

2167

2.01

39.02

1.1

6.32

5.65

u/ml

0.29

251

934

Sleep apnoea

889

3579

1.62

36.97

1.1

3.73

4.15

u/ml

0.32

367

1446

Diarrhoea and gastroenteritis of presumed infectious origin

1127

4915

1.52

35.92

1.1

5.30

5.48

u/ml

0.10

484

2095

D07AA Corticosteroids, weak (group I)

286

1283

2.27

35.90

1.1

12.55

6.18

u/ml

3.19

201

565

Bronchiectasis

6.44

35.86

1.1

1.82

2.74

u/ml

0.25

Voice disturbances

281

1250

2.28

35.86

1.1

3.23

3.66

u/ml

0.20

123

467

Asthma and opportunity respiratory infection

7.97

35.85

1.1

1.0

1.93

2.77

u/ml

0.19

Early onset COPD, excluding more controls

134

415

3.26

34.76

1.1

1.0

7.34

3.70

u/ml

0.85

119

Asthma mixed form (mode)

157

4.96

34.74

1.1

1.0

5.16

3.53

u/ml

0.38

Asthma mixed form (mode), excluding more controls

158

4.93

34.48

1.1

1.0

5.16

3.60

u/ml

0.36

Migraine

725

3600

1.65

33.69

1.1

7.39

5.45

u/ml

0.75

297

1534

Gastro-oesophageal reflux disease

647

3384

1.66

31.49

1.1

3.81

4.76

u/ml

0.65

252

1383

Polypectomy (DHB20)

217

4.11

31.43

1.2

1.1

2.09

2.69

u/ml

0.35

Migraine, single triptan purchase ok & required. ICD-code if available is included

983

4422

1.52

31.12

1.1

6.94

5.01

u/ml

1.03

399

1903

Triptan medication for migraine, single purchase ok

983

4422

1.52

31.12

1.1

6.94

5.01

u/ml

1.03

399

1903

Other acute lower respiratory infections

563

3163

1.71

31.00

1.1

7.12

5.59

u/ml

0.70

292

1387

Other and unspecified urticaria

290

1391

2.12

30.85

1.1

4.57

6.09

u/ml

0.64

152

575

Pain in joint

673

2618

1.65

30.33

1.1

5.84

5.34

u/ml

0.18

303

1132

Symptoms and signs involving speech and voice

306

1507

2.05

30.14

1.1

3.98

3.82

u/ml

0.06

137

578

Dentofacial anomalies [including malocclusion]

892

4748

1.52

29.41

1.1

4.91

5.28

u/ml

0.18

394

1994

COPD/asthma/ILD related infections

1113

3793

1.48

29.38

1.1

1.0

5.98

5.08

u/ml

0.54

492

1539

COPD/asthma related infections

1113

3793

1.48

29.38

1.1

1.0

5.98

5.08

u/ml

0.54

492

1539

Episodal and paroxysmal disorders

1241

4432

1.43

28.04

1.1

6.30

5.45

u/ml

0.45

538

1929

Headache

803

4254

1.52

26.41

1.1

7.18

5.41

u/ml

0.90

336

1798

Dermatitis

537

3297

1.63

25.19

1.1

1.0

4.93

3.65

u/ml

0.85

272

1225

Any death

1551

0.28

24.78

1.0

1.71

3.54

u/ml

1.32

615

Intestinal infectious diseases

1180

4830

1.40

24.36

1.1

4.73

5.53

u/ml

0.67

495

2056

Idiopathic urticaria

116

4.91

23.90

1.1

4.96

6.86

u/ml

0.25

Recurrent or chronic depression

489

2076

1.67

23.60

1.1

7.22

4.46

u/ml

0.79

203

869

COPD

176

627

2.30

22.73

1.1

1.0

6.31

2.48

u/ml

1.23

200

Malignant neoplasm

369

3727

0.58

22.64

1.0

1.1

3.07

4.43

u/ml

1.04

131

1523

Other chronic obstructive pulmonary disease

167

591

2.34

22.35

1.1

1.0

6.51

2.45

u/ml

1.28

185

Acute bronchitis

375

2130

1.74

22.30

1.1

4.98

5.36

u/ml

0.16

182

908

Any event in cancer register

466

4406

0.62

22.20

1.0

1.1

3.50

4.82

u/ml

1.07

165

1820

Depression or dysthymia

644

2301

1.55

22.17

1.1

6.43

4.28

u/ml

1.06

282

965

Dermatographic urticaria

114

421

2.78

22.12

1.1

2.15

3.87

u/ml

1.27

161

Coxibs

272

722

2.00

22.01

1.1

8.90

6.00

u/ml

0.54

103

347

Abnormalities of heart beat

316

1730

1.80

21.37

1.1

6.94

5.10

u/ml

0.41

138

694

Allergic contact dermatitis

171

778

2.23

21.00

1.1

6.11

3.15

u/ml

1.26

277

Solid cancers, helper endpoint

363

3598

0.59

20.89

1.0

1.1

3.02

4.11

u/ml

0.75

125

1459

Abnormal findings on diagnostic imaging of lung

261

1325

1.90

20.79

1.1

4.25

3.09

u/ml

0.50

117

496

Temporomandibular joint disorders, including avohilmo

591

3847

1.53

20.74

1.1

4.59

5.72

u/ml

0.75

282

1596

Atopic conjunctivitis

257

3.25

20.66

1.1

6.87

5.34

u/ml

0.32

108

Conjunctivitis (acute, non atopic)

319

1805

1.78

20.54

1.1

6.86

6.45

u/ml

0.12

158

752

Diabetes, insulin treatment (Kela reimbursement)

455

4332

0.63

20.05

1.1

5.67

4.38

u/ml

0.62

200

1775

Pain in throat and chest

843

3550

1.43

20.00

1.1

5.48

5.31

u/ml

0.06

344

1462

Acetic acid derivatives and related substances

258

688

1.96

19.80

1.1

5.94

5.72

u/ml

0.05

325

Malignant neoplasm, wide definition for exclusion

424

3961

0.62

19.59

1.0

1.1

2.99

4.51

u/ml

1.48

151

1633

Triptan medication for migraine, min. 3 purchases

770

4118

1.44

19.26

1.1

6.80

5.20

u/ml

0.74

303

1725

Other and unspecified dermatitis

434

2725

1.60

19.05

1.1

1.0

4.54

3.68

u/ml

0.50

218

1032

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

447

4206

0.64

18.93

1.1

5.71

4.41

u/ml

0.61

197

1724

Special screening examination for infectious and parasitic diseases

410

1857

1.64

18.80

1.1

1.0

5.36

5.52

u/ml

0.05

177

735

Irritable bowel syndrome

307

1772

1.75

18.74

1.1

4.54

4.78

u/ml

0.07

121

739

Diabetes medication

564

4970

0.67

18.71

1.1

5.04

4.71

u/ml

0.14

253

2039

Mycoses

861

5411

1.39

18.32

1.1

4.90

5.24

u/ml

0.19

342

2316

Simple and mucopurulent chronic bronchitis

5.38

18.28

1.1

1.42

4.69

u/ml

0.54

Diabetes mellitus

577

4966

0.68

18.23

1.1

6.03

4.83

u/ml

0.60

262

2043

Diabetes, varying definitions

572

4934

0.68

18.01

1.1

5.97

4.82

u/ml

0.56

258

2028

Renal tubulo-interstitial diseases

381

4517

0.63

17.98

1.1

5.12

5.16

u/ml

0.01

165

1896

Pain (limb, back, neck, head abdominally)

774

2714

1.43

17.96

1.1

6.49

5.56

u/ml

0.39

341

1196

Eosinophilic disease (BM)

7.86

17.95

1.2

1.0

1.03

2.34

u/ml

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

476

1515

1.59

17.67

1.1

1.0

5.01

5.72

u/ml

0.37

204

668

Exposure to unspecified factor

1014

5458

1.34

16.88

1.1

5.45

5.46

u/ml

0.00

464

2318

Disorders of lacrimal system

349

2140

1.64

16.79

1.1

4.46

4.67

u/ml

0.08

140

849

Other disorders of lacrimal gland

292

1735

1.69

16.09

1.1

4.62

4.10

u/ml

0.20

116

679

Codeine

992

4021

1.35

16.06

1.1

5.51

4.81

u/ml

0.35

417

1661

Other headache syndromes

426

2787

1.54

15.68

1.1

1.0

8.42

4.58

u/ml

1.10

177

1131

Pain and other conditions associated with female genital organs and menstrual cycle

306

1704

1.67

15.58

1.1

5.07

6.26

u/ml

0.35

119

752

Codeine or tramadol medication

1103

4597

1.32

15.49

1.1

5.39

4.75

u/ml

0.34

458

1886

All kidney diseases

547

5371

0.69

15.47

1.1

5.03

5.21

u/ml

0.08

241

2265

Tonsillectomy and adenotomy

831

4263

1.37

15.35

1.1

6.24

5.78

u/ml

0.20

378

1867

Neurological diseases

1011

3822

1.33

15.26

1.1

7.15

5.52

u/ml

0.87

446

1703

Low back pain

763

3999

1.38

14.97

1.1

5.04

4.83

u/ml

0.10

318

1665

Opioids

1053

4167

1.32

14.68

1.1

6.33

5.07

u/ml

0.66

452

1748

Neurotic, stress-related and somatoform disorders

957

5082

1.32

14.46

1.1

6.52

4.86

u/ml

0.93

432

2125

Anxiety disorders

960

5083

1.32

14.39

1.1

6.56

4.85

u/ml

0.97

433

2125

Migraine with aura

330

2087

1.60

14.31

1.1

8.70

5.27

u/ml

0.73

146

874

Schizophrenia

1066

0.23

14.25

1.1

8.43

4.06

u/ml

—

449

Propionic acid derivatives

283

838

1.71

14.15

1.1

6.09

7.00

u/ml

0.28

120

422

Abdominal and pelvic pain

1004

3839

1.32

14.01

1.1

4.88

5.75

u/ml

0.80

423

1690

Other viral diseases

500

3439

1.45

14.00

1.1

6.33

6.23

u/ml

0.03

232

1547

Soft tissue disorders related to use, overuse and pressure

207

1163

1.79

13.99

1.1

1.0

3.29

3.67

u/ml

0.18

422

Other (not insulin) diabetes medications

467

4028

0.69

13.96

1.1

4.77

4.14

u/ml

0.26

205

1586

Other bacterial diseases

439

4317

0.68

13.76

1.1

5.22

5.07

u/ml

0.06

202

1803

Biguanides

436

3896

0.68

13.69

1.1

4.58

4.09

u/ml

0.19

186

1532

Medical observation and evaluation for suspected diseases and conditions

672

2472

1.40

13.60

1.1

1.0

5.53

5.77

u/ml

0.10

332

985

Caries of enamel

931

5136

1.31

13.45

1.1

5.35

5.40

u/ml

0.03

421

2152

Type 2 diabetes

522

4314

0.70

13.36

1.1

5.50

4.15

u/ml

0.66

229

1707

Other antidepressants

974

3811

1.31

13.34

1.1

6.80

4.59

u/ml

1.37

430

1597

Symptoms and signs involving the digestive system and abdomen

999

3839

1.31

13.24

1.1

4.68

5.75

u/ml

1.04

415

1690

Heartburn

111

514

2.19

13.23

1.0

1.1

2.80

4.08

u/ml

0.45

213

Eosinophilia

5.63

13.16

1.2

1.0

1.03

7.66

u/ml

—

Other bacterial diseases

559

4935

0.72

13.09

1.1

5.20

5.12

u/ml

0.03

262

2060

Other dorsopathies, not elsewhere classified

1057

4287

1.29

13.08

1.1

6.22

5.09

u/ml

0.68

461

1814

Schizophrenia, schizotypal and delusional disorders

113

2283

0.49

13.07

1.1

6.54

4.81

u/ml

0.33

968

Anti-inflammatory and antirheumatic products, non-steroids

278

838

1.68

13.07

1.1

5.35

7.00

u/ml

0.70

118

422

Schizophrenia or delusion

113

2279

0.49

13.01

1.1

6.54

4.82

u/ml

0.33

967

Early onset COPD

134

678

1.99

12.58

1.1

1.0

7.34

2.69

u/ml

1.35

254

Haemorrhage from respiratory passages

189

958

1.79

12.56

1.1

1.0

3.71

4.65

u/ml

0.37

364

Insulin medication

214

2986

0.60

12.35

1.1

5.71

4.63

u/ml

0.37

1264

Dysphagia

156

839

1.87

12.22

1.1

1.0

5.32

3.08

u/ml

0.77

338

Diseases of the musculoskeletal system and connective tissue

729

2715

1.35

12.17

1.1

6.76

5.88

u/ml

0.35

328

1209

Diseases of middle ear and mastoid

689

4206

1.35

12.13

1.1

6.45

5.83

u/ml

0.23

326

1860

Other specific joint derangements/joint disorders

844

4168

1.31

12.12

1.0

1.1

5.75

5.47

u/ml

0.11

364

1784

Dorsalgia

1017

4249

1.29

12.08

1.1

6.01

5.03

u/ml

0.53

428

1792

Other special examinations and investigations of persons without complaint or reported diagnosis

666

2472

1.37

12.07

1.1

1.0

5.29

5.77

u/ml

0.25

311

985

Certain infectious and parasitic diseases

756

2832

1.34

12.02

1.1

1.0

4.62

5.42

u/ml

0.47

318

1191

Other joint disorders

1037

4282

1.28

11.94

1.1

6.68

5.46

u/ml

0.64

458

1845

Bronchitis, not specified as acute or chronic

256

2.60

11.74

1.0

7.16

3.26

u/ml

0.74

Anxiety disorders, excluding more controls

854

4275

1.30

11.68

1.1

5.96

4.70

u/ml

0.69

387

1741

Dorsopathies

1090

4374

1.27

11.65

1.1

6.18

5.17

u/ml

0.61

477

1869

COPD (mode)

356

2.19

11.56

1.1

1.0

7.15

3.59

u/ml

0.58

109

Type 2 diabetes, definitions combined, including avohilmo

492

3990

0.72

11.55

1.1

5.33

4.07

u/ml

0.56

216

1569

Oxicams

154

462

1.90

11.42

1.1

3.83

3.81

u/ml

0.00

216

Candidiasis

279

1793

1.57

11.39

1.1

4.27

5.21

u/ml

0.34

110

770

Type 2 diabetes, definitions combined

481

3933

0.72

11.32

1.1

5.41

4.03

u/ml

0.62

212

1543

ILD, hospital admissions 1, main diag only

255

2.57

11.29

1.0

1.1

1.52

3.36

u/ml

0.90

100

Type 2 diabetes, strict (exclude DM1)

482

3936

0.72

11.25

1.1

5.41

4.05

u/ml

0.62

213

1544

Schizophrenia or delusion, excluding more controls

113

2147

0.52

11.23

1.1

6.54

4.43

u/ml

0.43

885

Soft tissue disorders

1093

4469

1.26

11.18

1.1

5.14

5.75

u/ml

0.37

483

1947

Migraine with aura and triptan purchases

225

1395

1.63

10.80

1.1

9.74

4.95

u/ml

0.74

101

609

Other viral diseases, not elsewhere classified

337

2275

1.48

10.68

1.1

7.61

6.41

u/ml

0.35

150

1025

Malignant neoplasm of breast, including Hilmo

153

1727

0.57

10.63

1.0

1.1

2.69

3.45

u/ml

0.32

641

Neurological diseases, wide definition

467

1657

1.42

10.62

1.1

6.80

6.01

u/ml

0.21

204

784

Malignant neoplasm of breast, HER2-negative, including Hilmo

153

1727

0.57

10.62

1.0

1.1

2.69

3.45

u/ml

0.32

641

Other respiratory diseases principally affecting the interstitium

362

2.25

10.58

1.0

1.1

1.95

2.73

u/ml

0.35

148

Viral infections characterized by skin and mucous membrane lesions

823

5495

1.28

10.50

1.1

5.70

5.36

u/ml

0.19

352

2351

Cystitis

795

3653

1.30

10.42

1.1

4.95

5.40

u/ml

0.25

315

1542

Allergic urticaria

109

553

2.00

10.35

1.2

1.1

8.66

5.20

u/ml

0.65

235

Mental and behavioural disorders due to alcohol, excluding acute intoxication

143

2489

0.57

10.35

1.1

5.26

4.52

u/ml

0.19

1017

Selective serotonin reuptake inhibitors

940

3872

1.27

10.22

1.1

7.23

4.66

u/ml

1.54

400

1637

Malignant neoplasm of breast, HER2-negative

141

1623

0.57

10.16

1.0

1.1

2.75

3.47

u/ml

0.30

601

Myalgia

237

1509

1.58

10.14

1.1

6.25

5.21

u/ml

0.17

107

607

All anxiety disorders

745

4558

1.30

10.14

1.1

5.86

4.99

u/ml

0.50

334

1915

Malignant neoplasm of breast

146

1658

0.57

10.12

1.0

1.1

2.75

3.49

u/ml

0.30

615

Acute pharyngitis

213

1314

1.62

10.09

1.1

7.40

6.59

u/ml

0.18

104

595

Type 2 diabetes, wide definition

285

2720

0.67

10.00

1.0

1.1

4.24

3.61

u/ml

0.26

128

1029

Alcohol use disorder, ICD-based

131

2315

0.56

9.88

1.1

5.37

4.62

u/ml

0.18

949

ILD, hospital admissions

297

2.34

9.87

1.0

1.1

1.52

2.97

u/ml

0.76

121

Other interstitial pulmonary diseases

297

2.34

9.87

1.0

1.1

1.52

2.95

u/ml

0.74

122

Vocal cord dysfunction

151

770

1.77

9.85

1.2

1.0

3.68

3.67

u/ml

0.00

287

Interstitial lung disease

298

2.33

9.80

1.0

1.1

1.52

2.95

u/ml

0.74

122

Interstitial lung disease endpoints

298

2.33

9.80

1.0

1.1

1.52

2.95

u/ml

0.74

122

Cerebrovascular diseases

180

2067

0.61

9.75

1.0

1.1

4.34

3.23

u/ml

0.40

788

Parasetamol

846

3360

1.28

9.70

1.1

5.76

5.50

u/ml

0.10

357

1461

Kela-code for severe mental illness

151

2554

0.59

9.68

1.1

5.44

4.59

u/ml

0.20

1070

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

394

2503

1.41

9.64

1.1

3.41

4.21

u/ml

0.47

174

988

Paracetamol or NSAID medication

196

588

1.69

9.63

1.1

5.67

7.65

u/ml

0.69

303

Other chronic obstructive pulmonary disease, including avohilmo

230

1212

1.57

9.47

1.1

1.0

5.54

3.18

u/ml

0.90

115

459

Other diseases of hard tissues of teeth

472

1767

1.39

9.44

1.1

3.29

4.83

u/ml

1.55

205

700

Gastrointestinal diseases

759

2951

1.29

9.43

1.1

4.64

6.24

u/ml

1.49

325

1305

Other soft tissue disorders, not elsewhere classified

931

4359

1.26

9.38

1.1

5.21

5.70

u/ml

0.23

397

1887

Diseases of oesophagus, stomach and duodenum

958

4599

1.25

9.27

1.1

4.58

5.02

u/ml

0.21

397

1920

Other and unspecified nonorganic psychotic disorders

1644

0.50

9.26

1.1

7.41

5.26

u/ml

0.29

707

Insulin, combination of fast acting with intermediate-acting or long-acting

214

3018

0.65

9.21

1.1

5.71

4.70

u/ml

0.33

1274

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

243

2.23

9.09

1.0

1.57

2.33

u/ml

0.52

Disorders of synovium and tendon

476

3089

1.35

9.02

1.0

1.1

4.36

4.80

u/ml

0.21

194

1246

Anxiety (asthma-related co-morbidities)

721

4375

1.28

8.90

1.1

5.93

4.81

u/ml

0.68

325

1826

Alcohol use disorder, Swedish definition

208

2937

0.65

8.90

1.1

4.82

4.48

u/ml

0.11

102

1204

Suppurative and unspecified otitis media

487

3223

1.35

8.84

1.1

7.33

6.25

u/ml

0.33

242

1476

Other and unspecified tonsillitis

452

2804

1.36

8.81

1.1

6.11

5.79

u/ml

0.11

197

1223

264

3409

0.68

8.81

1.1

4.73

5.05

u/ml

0.12

130

1409

Acute bronchiolitis

125

630

1.82

8.79

1.1

14.48

9.66

u/ml

0.64

346

Injuries to the wrist and hand

960

5390

1.24

8.75

1.1

6.56

5.11

u/ml

0.97

436

2281

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

212

1366

1.57

8.74

1.1

7.09

5.51

u/ml

0.39

573

Pruritus

481

1.97

8.74

1.0

1.1

5.41

2.40

u/ml

0.59

164

Diseases of the ear and mastoid process

1171

4838

1.22

8.72

1.1

5.66

5.32

u/ml

0.18

525

2040

COPD, hospital admissions

167

855

1.66

8.57

1.1

1.0

6.44

2.66

u/ml

1.21

318

Functional dyspepsia

211

1364

1.56

8.52

1.1

3.65

4.24

u/ml

0.19

538

243

3247

0.67

8.51

1.1

4.81

5.19

u/ml

0.14

122

1355

COPD, early/later onset

168

862

1.65

8.45

1.1

1.0

6.44

2.64

u/ml

1.23

321

Later onset COPD, excluding more controls

3.35

8.45

1.0

0.92

0.77

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

279

3719

0.69

8.44

1.1

6.39

4.87

u/ml

0.68

140

1537

Alcohol dependence

1232

0.45

8.44

1.1

5.19

3.83

u/ml

0.18

482

Dermatophytosis

515

3907

1.32

8.43

1.0

1.1

5.67

5.19

u/ml

0.18

207

1651

Allergic colitis

271

2.33

8.37

1.1

8.99

9.10

u/ml

0.01

149

Substance abuse

264

3592

0.69

8.30

1.1

6.54

4.89

u/ml

0.73

134

1490

All chronic kidney diseases

172

2223

0.63

8.26

1.0

1.1

7.44

5.37

u/ml

0.54

948

Vasomotor rhinitis (mode)

277

2.26

8.25

1.1

7.42

4.91

u/ml

0.20

113

Stroke, including SAH

123

1531

0.58

8.22

1.0

1.1

3.41

3.19

u/ml

0.05

588

Exposure to other specified factors

734

5369

1.26

8.16

1.1

6.36

5.17

u/ml

0.50

343

2287

Trochanteric bursitis

528

1.89

8.15

1.0

1.1

1.60

3.26

u/ml

1.20

182

Inflammatory diseases of prostate (prostatitis)

344

2.11

8.09

1.1

1.0

2.55

3.75

u/ml

0.34

143

Renal failure

1191

0.49

8.01

1.0

1.1

6.54

3.56

u/ml

0.49

479

Disease of hard tissues of teeth, NOS

443

1710

1.36

7.98

1.1

4.02

4.63

u/ml

0.29

186

661

Fenamates

114

425

1.83

7.97

1.1

5.57

4.51

u/ml

0.19

196

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

449

1.96

7.95

1.1

4.10

4.25

u/ml

0.04

183

Substance abuse, excluding more controls

264

3231

0.69

7.89

1.1

6.54

4.51

u/ml

1.00

134

1325

Depression medications

489

1847

1.34

7.83

1.1

8.90

5.61

u/ml

1.25

217

807

Periodontitis

489

4271

0.76

7.74

1.0

1.1

4.65

4.21

u/ml

0.22

207

1721

Chronic periodontitis, including avohilmo

487

4264

0.76

7.72

1.0

1.1

4.65

4.19

u/ml

0.23

207

1719

STROKE

202

2070

0.66

7.68

1.0

1.1

3.31

3.60

u/ml

0.11

788

Other menopausal disorders

221

817

1.53

7.63

1.1

1.0

3.45

3.24

u/ml

0.08

302

Mental and behavioural disorders due to alcohol

213

3028

0.67

7.57

1.1

5.25

4.83

u/ml

0.14

109

1262

Lower back pain or/and sciatica

944

5066

1.22

7.55

1.1

5.88

4.85

u/ml

0.51

385

2119

Restless leg syndrome

101

558

1.82

7.49

1.1

7.02

3.88

u/ml

0.51

213

Inflammatory diseases of female pelvic organs

627

3635

1.27

7.46

1.1

4.51

5.49

u/ml

0.57

251

1483

Unspecified mental disorder

202

3002

0.67

7.41

1.1

4.80

5.07

u/ml

0.07

104

1261

Enthesopathies of lower limb, excluding foot

188

1228

1.54

7.33

1.0

1.1

5.14

4.14

u/ml

0.26

475

Insulin, intermediate and long-acting

187

2737

0.66

7.31

1.1

6.22

4.50

u/ml

0.58

1163

Lichen simplex chronicus and prurigo

185

2.46

7.26

1.1

4.54

3.80

u/ml

0.10

Organic, including symptomatic, mental disorders

802

0.47

7.19

1.0

1.60

3.21

u/ml

0.88

317

Non-allergic asthma

289

2.13

7.05

1.1

1.0

1.73

3.32

u/ml

0.65

101

Examination and observation for other reasons

546

2456

1.29

7.02

1.1

1.0

3.94

5.78

u/ml

1.75

224

974

Persons encountering health services for examination and investigation

625

2472

1.27

6.97

1.1

1.0

4.53

5.77

u/ml

0.79

274

985

Autoimmune diseases excluding thyroid diseases

726

4888

0.81

6.97

1.1

5.33

5.51

u/ml

0.09

309

2136

Migraine without aura

270

1920

1.42

6.89

1.1

4.60

5.45

u/ml

0.33

112

837

Herpesviral [herpes simplex] infections

255

1795

1.43

6.88

1.1

6.17

4.91

u/ml

0.48

113

748

Other and unspecified vaccines and biological substances

4.49

6.87

1.1

3.36

9.53

u/ml

0.76

Persons encountering health services for specific procedures and health care

1038

5206

1.20

6.85

1.1

6.25

5.05

u/ml

0.71

532

2149

Acute tubulo-interstitial nephritis

278

3324

0.72

6.83

1.1

4.82

5.17

u/ml

0.11

120

1412

GASTRO-related operations

927

3839

1.21

6.83

1.1

5.00

6.04

u/ml

0.85

397

1699

Any gastric operation

927

3839

1.21

6.83

1.1

5.00

6.04

u/ml

0.85

397

1699

Stroke, excluding SAH

110

1346

0.59

6.81

1.0

3.10

3.31

u/ml

0.05

512

Autoimmune diseases excluding thyroid diseases, strict definition

713

4813

0.81

6.80

1.1

5.40

5.55

u/ml

0.08

305

2114

Depression

915

5140

1.21

6.79

1.1

7.30

4.81

u/ml

1.53

416

2135

Occupational exposure to risk-factors

115

2.83

6.77

1.1

0.60

3.35

u/ml

1.95

Arthropathies

1021

4319

1.20

6.71

1.1

6.05

5.65

u/ml

0.16

450

1871

Acute suppurative otitis media

385

2713

1.33

6.68

1.1

5.96

6.60

u/ml

0.24

190

1258

Otalgia

478

1.84

6.66

1.2

1.1

6.23

6.53

u/ml

0.05

220

Internal derangement of knee

311

2265

1.37

6.65

1.1

6.12

4.52

u/ml

0.60

126

897

Other diseases of lip and oral mucosa

303

2213

1.37

6.57

1.1

3.61

4.84

u/ml

0.76

132

888

Other diseases of urinary system

888

4130

1.21

6.54

1.1

4.95

5.48

u/ml

0.33

366

1757

Other anxiety disorders

562

3870

1.26

6.51

1.1

6.74

5.24

u/ml

0.77

258

1662

Benign neoplasm: Liver/bile ducts

118

2.77

6.49

1.0

1.1

5.55

6.51

u/ml

0.09

Chronic gastritis

115

688

1.68

6.49

1.1

1.0

8.26

3.57

u/ml

0.42

243

Unspecified chronic bronchitis

3.95

6.44

1.2

1.1

3.79

5.09

u/ml

—

Other general symptoms and signs

394

1.91

6.43

1.1

7.21

7.45

u/ml

0.02

190

Erysipelas

290

3021

0.73

6.42

1.0

1.1

5.11

3.96

u/ml

0.64

148

1198

Cervicocranial syndrome

491

1.81

6.39

1.1

4.57

3.26

u/ml

0.21

193

Benign neoplasm: Liver

108

2.84

6.37

1.0

1.1

5.92

6.30

u/ml

0.03

Intestinal infectious diseases

868

5480

1.20

6.34

1.1

4.61

5.65

u/ml

1.05

401

2325

Malignant neoplasm of breast, ER-positive, including Hilmo

1276

0.59

6.33

1.1

1.62

3.14

u/ml

1.76

460

Accidents

819

3373

1.22

6.33

1.1

6.37

5.03

u/ml

0.70

364

1389

Migraine without aura and triptan purchases

217

1510

1.45

6.31

1.1

4.90

4.78

u/ml

0.03

665

Peritonsillar abscess

174

1160

1.51

6.25

1.1

1.0

5.31

5.00

u/ml

0.08

430

Selective deficiency of immunoglobulin G [IgG] subclasses

7.99

6.20

1.0

1.1

2.59

2.71

u/ml

—

Other noninfective gastroenteritis and colitis

212

1473

1.45

6.15

1.1

5.44

6.09

u/ml

0.19

111

649

Disorders of eyelid, lacrimal system and orbit

653

4023

1.24

6.15

1.1

4.73

5.04

u/ml

0.16

271

1668

Symptoms and signs involving the skin and subcutaneous tissue

574

4510

1.25

6.15

1.1

5.76

5.01

u/ml

0.36

232

1877

Malignant neoplasm of breast, HER-positive

1244

0.59

6.04

1.1

1.62

3.09

u/ml

1.66

445

Other enthesopathies

228

1619

1.41

5.91

1.1

4.41

3.61

u/ml

0.21

602

Other diseases of oesophagus

250

2.09

5.86

1.1

1.84

3.31

u/ml

0.70

103

Metabolic disorders

527

4016

0.80

5.84

1.1

2.51

4.95

u/ml

4.82

229

1646

Olecranon bursitis

167

2.36

5.82

1.1

6.44

3.48

u/ml

0.64

ILD, hospital admission 2, with pulmonary infections

161

2.37

5.79

1.1

1.96

4.43

u/ml

0.71

Non-invasive ventilation

219

1381

1.42

5.78

1.1

2.77

4.55

u/ml

1.54

128

552

Mood [affective] disorders

942

5153

1.19

5.78

1.1

6.99

4.80

u/ml

1.32

428

2145

Emphysema

3.16

5.73

1.2

1.1

2.48

2.72

u/ml

—

COPD, hospital admission 2, with asthma infections

106

549

1.66

5.68

1.1

1.0

6.89

2.83

u/ml

0.83

214

Condition for Implicit Sepsis (Organ dysfunction codes)

444

3969

0.79

5.68

1.1

4.75

4.98

u/ml

0.10

191

1675

Cerebrovascular diseases (FINNGEN)

130

1416

0.65

5.66

1.1

1.0

4.71

3.98

u/ml

0.16

538

Acute appendicitis, no complications

534

4280

1.25

5.66

1.0

1.1

5.06

4.69

u/ml

0.16

211

1768

Pain in thoracic spine

131

842

1.57

5.62

1.1

8.17

4.11

u/ml

0.78

322

Sub-endpoint used in defining T1D endpoints

127

1919

0.65

5.61

1.1

6.62

5.31

u/ml

0.35

859

Mood disorders

941

5154

1.18

5.60

1.1

6.99

4.80

u/ml

1.32

428

2145

Somatoform disorder

152

1011

1.51

5.59

1.1

8.02

4.02

u/ml

0.44

401

Benign neoplasm: Colon, unspecified

564

1.69

5.58

1.1

3.49

3.27

u/ml

0.04

204

Other external causes of accidental injury

809

3373

1.20

5.58

1.1

6.20

5.03

u/ml

0.58

361

1389

Dipeptidyl peptidase 4 (DPP-4) inhibitors

117

1467

0.64

5.55

1.0

8.31

2.91

u/ml

1.00

539

Hypertrophy of breast in women and men

183

1265

1.46

5.55

1.1

6.71

4.48

u/ml

0.49

497

Other viral diseases

335

2548

1.32

5.54

1.1

8.14

6.21

u/ml

0.70

159

1155

Mouth breathing

299

2245

1.34

5.46

1.1

4.58

5.29

u/ml

0.26

131

950

Type 1 diabetes

127

1933

0.65

5.44

1.1

6.62

5.29

u/ml

0.36

857

Endometriosis of pelvic peritoneum

173

1132

1.47

5.42

1.1

2.56

4.71

u/ml

1.47

470

Transport accidents

451

3075

1.27

5.41

1.1

1.0

4.49

4.86

u/ml

0.18

195

1271

Ischaemic Stroke, excluding all haemorrhages

1192

0.62

5.41

1.1

1.0

2.74

3.18

u/ml

0.11

447

Other neurological diseases

255

2707

0.74

5.38

1.1

3.34

4.20

u/ml

0.46

115

1088

Heart failure, not strict

246

2273

0.73

5.37

1.1

4.20

3.91

u/ml

0.08

104

901

Other degenerative diseases of the nervous system

766

0.52

5.37

1.1

1.0

1.74

3.04

u/ml

0.64

288

Disturbances of skin sensation

262

1938

1.36

5.36

1.1

5.55

4.75

u/ml

0.22

792

Psychiatric diseases

894

3775

1.19

5.36

1.1

6.72

4.86

u/ml

1.13

393

1585

Drug-induced adrenocortical insufficiency

3.04

5.30

1.1

7.60

4.96

u/ml

—

Excessive attrition of teeth

537

4362

1.24

5.30

1.1

4.19

5.33

u/ml

0.80

241

1803

Other disorders of penis

446

1.76

5.29

1.1

3.24

5.52

u/ml

0.92

227

Dislocation, sprain and strain of joints and ligaments of knee

592

4477

1.22

5.23

1.1

6.53

4.99

u/ml

0.51

263

1844

Polyarthropathies

380

3167

0.78

5.17

1.1

2.67

4.94

u/ml

3.41

156

1297

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

621

0.41

5.17

1.0

1.1

2.44

2.85

u/ml

—

226

COPD, hospital admissions 1, only main diagnosis

109

583

1.60

5.16

1.1

3.99

2.82

u/ml

0.27

221

Idiopathic pulmonary fibrosis

2.80

5.14

1.0

1.1

1.26

2.69

u/ml

0.58

Other extrapyramidal and movement disorders in other diseases

139

925

1.51

5.12

1.1

5.57

3.36

u/ml

0.52

359

Acute and transient psychotic disorders

748

0.46

5.10

1.1

6.46

4.04

u/ml

0.36

302

Allergic contact dermatitis due to drugs in contact with skin

2.95

5.06

1.0

1.1

15.54

5.43

u/ml

—

Persons encountering health services in other circumstances

373

2907

1.28

5.06

1.1

5.78

5.67

u/ml

0.04

149

1267

Diseases of appendix

658

4934

1.20

5.04

1.0

1.1

4.87

4.70

u/ml

0.08

259

2034

Appendicitis, broad definition

655

4928

1.20

5.03

1.0

1.1

4.87

4.70

u/ml

0.07

259

2032

Chondrocostal junction syndrome [Tietze]

147

2.34

5.03

1.0

1.1

5.35

7.34

u/ml

0.31

External causes of morbidity and mortality

690

2867

1.21

5.01

1.1

6.89

4.98

u/ml

0.96

309

1191

Dermatitis due to substances taken internally

240

2.02

4.95

1.0

1.1

7.12

4.45

u/ml

0.56

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

284

2154

1.32

4.95

1.1

5.53

5.08

u/ml

0.15

137

916

Other inflammation of eyelid

609

1.62

4.91

1.0

1.1

4.20

3.71

u/ml

0.09

238

Cervicalgia

141

951

1.49

4.89

1.1

4.25

3.76

u/ml

0.14

363

Other disorders of adrenal gland

235

2.03

4.87

1.1

4.96

5.36

u/ml

0.05

Unspecified acute lower respiratory infection

121

792

1.54

4.85

1.1

1.0

5.51

5.17

u/ml

0.08

312

ILD-related respiratory insufficiency

4.25

4.83

1.1

1.18

4.22

u/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

546

3548

1.22

4.77

1.0

1.1

3.85

4.75

u/ml

0.63

202

1416

5.78

4.76

1.1

1.64

2.27

u/ml

—

COPD related to multimorbidity

114

621

1.55

4.73

1.1

1.0

4.08

2.02

u/ml

0.71

225

Oesophagitis

151

2.27

4.73

1.1

3.60

4.32

u/ml

0.10

General symptoms and signs

1043

4512

1.16

4.73

1.1

5.84

5.35

u/ml

0.23

440

1930

Other and unspecified drugs and medicaments

390

1.76

4.63

1.1

4.18

4.58

u/ml

0.09

153

Dental pulpitis, including avohilmo

924

5161

1.16

4.59

1.1

4.93

5.33

u/ml

0.26

394

2167

Schizoaffective disorder

523

0.40

4.58

1.0

1.1

3.66

4.25

u/ml

0.12

214

Hypertrophy of breast

165

1164

1.43

4.57

1.1

5.38

4.58

u/ml

0.20

451

Diaphragmatic hernia

167

1181

1.42

4.53

1.0

1.1

1.40

2.80

u/ml

2.06

434

Female infertility, cervical, vaginal, other or unspecified origin

309

1550

1.30

4.53

1.1

6.94

5.64

u/ml

0.39

119

655

Disorders of the thyroid gland

804

4462

1.18

4.52

1.1

4.71

5.26

u/ml

0.23

309

1881

Acute renal failure

536

0.41

4.51

1.0

1.1

3.07

3.91

u/ml

—

211

Septicaemia

115

1607

0.67

4.51

1.1

6.01

4.67

u/ml

0.29

655

Provisional assignment of new diseases of uncertain etiology

442

3579

1.24

4.49

1.1

5.82

5.51

u/ml

0.12

209

1537

Spondylolisthesis/Spondylolysis

115

758

1.52

4.49

1.0

1.1

3.53

3.69

u/ml

0.04

287

Adenomyosis (Endometriosis of uterus)

608

1.59

4.48

1.1

1.0

1.76

3.99

u/ml

1.98

242

Lichen simplex chronicus

105

2.51

4.48

1.0

1.1

7.38

3.08

u/ml

0.42

Visual disturbances

349

2758

1.27

4.47

1.1

6.74

5.12

u/ml

0.45

171

1165

Type 1 diabetes, wide definition

119

1757

0.67

4.46

1.1

7.41

5.12

u/ml

0.65

790

Implicit Sepsis

332

3177

0.79

4.45

1.1

4.90

4.84

u/ml

0.02

150

1317

Nummular dermatitis

222

1.99

4.45

1.1

1.0

1.18

3.20

u/ml

1.08

Acute appendicitis

618

4844

1.20

4.43

1.0

1.1

4.77

4.65

u/ml

0.05

246

2001

Codes for special purposes

442

3586

1.23

4.42

1.1

5.82

5.50

u/ml

0.12

209

1542

Diseases of male genital organs

376

1497

1.27

4.39

1.1

4.53

5.56

u/ml

0.45

159

722

Iron deficiency

232

1.98

4.35

1.1

2.44

6.10

u/ml

1.12

Type 1 diabetes, wide definition, subgroup 1

115

1699

0.67

4.34

1.1

6.87

4.92

u/ml

0.55

760

COPD-related respiratory insufficiency

170

2.13

4.33

1.1

1.0

1.03

1.92

u/ml

0.70

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

115

755

1.52

4.32

1.2

1.1

8.47

7.26

u/ml

0.21

368

Hypothyreosis and Thyroxine purchase for inclusion criteria

777

4354

1.17

4.28

1.1

4.75

5.20

u/ml

0.18

291

1818

Recurrent aphthous stomatitis , including avohilmo

118

792

1.50

4.26

1.1

2.56

6.15

u/ml

2.70

351

Hypothyroidism, other/unspecified

755

4236

1.17

4.24

1.1

4.85

5.25

u/ml

0.15

283

1775

Nonalcoholic fatty liver disease

477

1.65

4.23

1.0

1.1

3.01

4.54

u/ml

0.42

185

Erysipelas

183

2201

0.73

4.19

1.0

1.1

5.46

3.49

u/ml

0.82

853

Viral pneumonia

619

1.56

4.18

1.1

9.60

4.46

u/ml

0.85

261

ILD, hospital admissions 3, with pneumonia sepsis

140

2.22

4.17

1.1

1.91

3.12

u/ml

0.33

Disorders of lipoprotein metabolism and other lipidaemias

351

2724

0.80

4.17

1.0

1.1

2.06

3.88

u/ml

2.54

154

1050

Excessive, frequent and irregular menstruation

412

1817

1.25

4.17

1.1

3.76

6.27

u/ml

2.16

178

800

Striking against or struck by other objects

319

2516

1.27

4.17

1.1

5.51

6.02

u/ml

0.19

127

1146

Viral warts

218

1639

1.34

4.13

1.1

5.30

5.92

u/ml

0.20

727

Hypothyroidism, strict autoimmune

658

3660

1.18

4.12

1.1

5.28

5.14

u/ml

0.04

254

1525

Dementia, including avohilmo

451

0.49

4.10

1.0

1.63

2.25

u/ml

0.15

177

Bacterial Sepsis

118

1470

0.68

4.09

1.0

1.1

3.85

4.25

u/ml

0.13

588

Degenerative diseases of the nervous system

294

0.35

4.08

1.1

0.13

1.61

u/ml

—

120

Spinal osteochondrosis

3.41

4.07

1.1

1.0

31.28

2.64

u/ml

—

Mood disorders, excluding more controls

832

4283

1.16

4.03

1.1

6.86

4.55

u/ml

1.24

375

1742

Diseases of salivary glands

240

1835

1.31

4.03

1.1

5.28

4.85

u/ml

0.10

100

747

Deep bite

149

928

1.42

3.99

1.1

13.00

7.97

u/ml

0.69

476

Liquid cancers, helper endpoint

1241

0.66

3.97

1.1

3.21

4.13

u/ml

0.38

512

Infections with a predominantly sexual mode of transmission

491

3801

1.21

3.96

1.1

5.69

6.01

u/ml

0.13

203

1660

Acute laryngitis and tracheitis

163

1161

1.39

3.96

1.1

5.33

7.25

u/ml

0.76

533

Visual disturbances and blindness

363

2926

1.24

3.95

1.1

6.57

5.07

u/ml

0.43

177

1239

Peroneal tendinitis

2.77

3.95

1.0

1.19

4.32

u/ml

—

Other disorders of patella

161

1164

1.39

3.93

1.1

3.60

3.87

u/ml

0.08

447

Adrenocortical insufficiency

171

2.07

3.92

1.1

5.83

3.42

u/ml

0.25

Peripheral artery disease

708

0.57

3.91

1.1

1.0

1.11

2.42

u/ml

1.62

267

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

607

4934

0.85

3.90

1.1

5.01

5.06

u/ml

0.02

270

2070

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

596

0.48

3.90

1.1

11.18

5.20

u/ml

0.64

258

Dislocation, sprain and strain of joints and ligaments at neck level

166

1209

1.38

3.90

1.1

6.95

5.47

u/ml

0.31

506

Diseases of external ear

239

1836

1.31

3.89

1.1

7.95

5.89

u/ml

0.35

107

774

Other nutritional deficiencies

596

4752

1.18

3.89

1.1

5.76

5.02

u/ml

0.25

257

1936

Generalized anxiety disorder

205

1545

1.34

3.86

1.1

7.15

5.67

u/ml

0.35

678

Transplanted organ and tissue status

499

0.44

3.86

1.0

1.1

13.16

5.96

u/ml

—

217

Implicit Sepsis

420

3733

0.82

3.86

1.1

4.65

5.02

u/ml

0.17

179

1560

Gluteal tendinitis

139

2.18

3.84

1.0

1.1

2.53

2.23

u/ml

0.06

Female infertility

332

1604

1.26

3.83

1.1

6.48

5.66

u/ml

0.25

128

684

Diagnoses used for exclusion with ILD

129

901

1.44

3.83

1.1

2.88

3.66

u/ml

0.29

352

Oedema, not elsewhere classified

191

1405

1.34

3.82

1.1

2.87

3.90

u/ml

0.79

569

Hypermobility syndrome

445

1.64

3.82

1.1

5.39

4.25

u/ml

0.19

176

Ovarian cyst

356

1646

1.25

3.81

1.1

5.30

5.96

u/ml

0.23

156

706

Tracheo-bronchomalasia

4.80

3.81

1.3

1.0

2.36

10.75

u/ml

—

Delirium, not induced by alcohol and other psychoactive substances

204

0.24

3.81

1.0

1.1

—

2.90

—

Continuous positive airway pressure

138

820

1.42

3.80

1.1

6.25

5.48

u/ml

0.13

336

Disorders of skin appendages

450

3724

1.21

3.79

1.1

5.27

5.74

u/ml

0.23

205

1613

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

667

5067

0.86

3.77

1.1

4.73

5.42

u/ml

0.36

289

2140

Pure hypercholesterolaemia

277

2296

0.79

3.76

1.0

1.1

2.46

3.85

u/ml

1.24

129

871

Pain in limb

718

4126

1.17

3.76

1.1

4.73

5.59

u/ml

0.59

295

1762

Infective dermatitis

415

1.65

3.75

1.1

7.61

2.87

u/ml

0.83

133

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

182

2.01

3.71

1.1

9.93

7.20

u/ml

—

Chronic conjunctivitis

135

2.18

3.69

1.0

1.1

6.78

5.29

u/ml

0.15

Other otitis externa (chronic)

304

1.76

3.69

1.1

13.71

4.51

u/ml

0.38

134

728

3793

1.16

3.68

1.1

1.0

4.86

5.08

u/ml

0.12

353

1539

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

728

3793

1.16

3.68

1.1

1.0

4.86

5.08

u/ml

0.12

353

1539

Subacute thyroiditis

162

2.06

3.67

1.0

3.44

6.08

u/ml

0.37

Candidiasis

104

704

1.49

3.66

1.1

5.04

3.48

u/ml

0.29

293

L04AD Calcineurin inhibitors

662

0.53

3.66

1.0

1.1

14.77

6.04

u/ml

0.74

295

Insulin, fast-acting

159

2153

0.74

3.66

1.1

7.18

4.88

u/ml

0.64

933

Ocular pain

505

1.58

3.64

1.1

4.85

4.38

u/ml

0.07

202

Follow-up examination after treatment for conditions other than malignant neoplasms

375

2017

1.23

3.63

1.1

1.0

3.89

5.70

u/ml

1.42

144

779

Other disorders of cornea

373

1.67

3.63

1.1

10.78

4.22

u/ml

1.37

145

Otitis externa

181

1352

1.34

3.63

1.1

7.74

5.39

u/ml

0.30

570

Cervical disc disorders

206

1567

1.32

3.63

1.1

1.0

4.14

3.50

u/ml

0.19

578

Insulin, fast-acting or short human

159

2149

0.74

3.62

1.1

7.18

4.82

u/ml

0.66

931

Struck by thrown, projected or falling objec

285

1.77

3.57

1.1

7.69

4.68

u/ml

0.31

120

Blepharochalasis

108

740

1.46

3.57

1.1

1.0

1.98

2.60

u/ml

0.27

263

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

171

2.02

3.56

1.0

1.1

5.54

4.46

u/ml

0.14

Vulvovaginal ulceration/inflammation in other diseases

485

1.58

3.55

1.1

5.99

4.21

u/ml

0.37

191

Type 1 diabetes, strict (exclude DM2)

1041

0.63

3.55

1.1

7.93

5.96

u/ml

0.33

476

Subjective visual disturbances

178

1332

1.34

3.53

1.1

6.68

5.08

u/ml

0.41

536

Fibromyalgia

565

1.53

3.52

1.1

3.89

3.10

u/ml

0.20

200

Noninflammatory disorders of female genital tract

454

1887

1.21

3.52

1.1

5.81

6.50

u/ml

0.24

184

839

Exclusions for E4_PCOS_CONSORTIUM

558

4110

0.85

3.51

1.1

3.57

5.44

u/ml

2.04

204

1745

Any dementia, excluding more controls

324

0.45

3.51

1.0

1.1

0.21

2.03

u/ml

—

125

Diarrhoea and gastroenteritis of presumed infectious origin

636

4920

1.17

3.51

1.1

4.59

5.75

u/ml

0.97

301

2101

Disorders of sclera, cornea, iris and ciliary body

417

3459

1.21

3.51

1.1

5.86

4.98

u/ml

0.48

196

1447

Anomalies of dental arch relationship, including avohilmo

238

1672

1.29

3.50

1.1

8.22

6.76

u/ml

0.25

116

778

Other noninflammatory disorders of vagina

401

1.63

3.48

1.0

1.1

2.81

3.38

u/ml

0.11

155

Sequelae of cerebrovascular disease

729

0.59

3.47

1.0

1.1

3.05

2.61

u/ml

0.09

275

Atypical facial pain

222

1.86

3.46

1.1

0.29

4.35

u/ml

—

Disorders of tooth development and eruption

178

1078

1.34

3.46

1.1

3.89

5.51

u/ml

0.57

459

Other septicaemia

100

1393

0.69

3.45

1.1

6.55

4.53

u/ml

0.43

568

Condition for Implicit Sepsis (Organ dysfunction codes)

554

4483

0.85

3.45

1.1

5.52

5.03

u/ml

0.23

233

1907

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.03

3.43

1.3

1.0

2.36

6.75

u/ml

—

Chronic periodontitis, complicated

187

2429

0.76

3.43

1.0

1.1

3.60

3.71

u/ml

0.03

924

Umbilical hernia

175

1313

1.34

3.42

1.1

2.42

3.64

u/ml

1.04

523

Prurigo nodularis

3.01

3.42

1.1

1.0

0.22

0.73

u/ml

—

Sulfonylureas

445

0.50

3.42

1.0

3.64

2.45

u/ml

0.30

162

Other symptoms and signs involving the circulatory and respiratory systems

230

1.84

3.42

1.1

1.0

2.64

4.94

u/ml

0.52

Lichen planus

388

1.63

3.39

1.0

1.1

7.12

2.77

u/ml

0.62

143

Malignant neoplasm of digestive organs

820

0.63

3.39

1.0

4.44

3.06

u/ml

0.37

322

Use of disulfiram, acamprosate or naltrexone

486

0.47

3.39

1.0

1.1

2.80

4.07

u/ml

0.32

186

Flat foot [pes planus] (acquired)

404

1.62

3.38

1.1

1.0

3.34

3.88

u/ml

0.14

145

Valvular heart disease excluding rheumatic fever

137

1358

0.73

3.38

1.1

2.90

5.09

u/ml

1.47

555

Benign neoplasm of other and ill-defined parts of digestive system

570

1.51

3.38

1.0

1.1

4.29

3.75

u/ml

0.12

210

Dialysis, with operation codes

485

0.47

3.36

1.0

1.1

4.56

4.57

u/ml

0.00

216

Viral and other specified intestinal infections

341

2690

1.23

3.34

1.1

4.58

7.07

u/ml

2.61

169

1256

Any dementia

320

0.46

3.33

1.0

1.1

0.21

1.52

u/ml

—

126

Short Achilles tendon (acquired)

108

2.25

3.33

1.0

1.39

2.59

u/ml

0.64

Other and unspecified rosacea

398

1.62

3.33

1.1

4.57

3.93

u/ml

0.12

143

Persons encountering health services for other counselling and medical advice, not elsewhere classified

985

4736

1.13

3.32

1.1

5.64

5.22

u/ml

0.21

449

2005

Injury, poisoning and certain other consequences of external causes

564

2401

1.18

3.32

1.1

5.52

5.09

u/ml

0.18

247

997

Hypertensive diseases

523

3475

0.85

3.31

1.1

3.27

4.29

u/ml

0.89

214

1394

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

255

1.78

3.31

1.0

1.1

1.95

4.00

u/ml

0.73

102

Mycoses

180

1364

1.32

3.31

1.1

5.02

4.31

u/ml

0.16

560

Noninfective enteritis and colitis

382

3159

1.21

3.30

1.1

6.14

5.58

u/ml

0.21

173

1375

Keratitis

270

2156

1.26

3.30

1.1

6.73

4.82

u/ml

1.01

130

884

Substance use, excluding alcohol

101

1444

0.70

3.29

1.0

1.1

8.03

5.25

u/ml

0.66

595

Nonsuppurative otitis media

293

2042

1.25

3.28

1.1

6.22

7.50

u/ml

0.44

145

969

Other contact dermatitis

369

1.64

3.27

1.1

10.00

2.95

u/ml

1.38

123

Other disorders of urethra and urinary system

541

3325

1.18

3.27

1.1

5.73

5.03

u/ml

0.30

215

1385

Unspecific neurodegenerative disorder

312

0.46

3.26

1.0

2.48

1.43

u/ml

—

129

Hyperkinetic disorders, excluding more controls

195

1435

1.31

3.25

1.1

11.28

6.30

u/ml

0.95

686

Other disorders of eyelid

172

1234

1.33

3.25

1.1

4.18

3.10

u/ml

0.29

462

Other deformities of toe(s)

2.35

3.25

1.0

1.1

0.66

4.95

u/ml

—

Hypertension

523

3467

0.85

3.23

1.1

3.27

4.29

u/ml

0.89

214

1392

Unspecified privation

520

1.53

3.23

1.1

2.38

4.75

u/ml

1.68

215

Type 1 diabetes, definitions combined

1041

0.65

3.23

1.1

8.96

5.87

u/ml

0.55

474

Ganglion

179

1361

1.32

3.23

1.0

1.1

3.52

5.22

u/ml

0.95

536

Appendectomy

584

4803

1.16

3.22

1.0

1.1

4.02

4.75

u/ml

0.50

241

1974

Inhalation and ingestion of food causing obstruction of respiratory tract

3.61

3.22

1.4

1.1

6.29

6.49

u/ml

—

Diseases of arteries, arterioles and capillaries

184

1774

0.76

3.22

1.0

2.83

3.21

u/ml

0.19

684

Other disorders of bone

166

1250

1.33

3.21

1.0

1.1

5.36

5.09

u/ml

0.06

507

Pleural plaque

2.58

3.21

1.1

0.50

2.29

u/ml

—

Hypothyroidism, levothyroxine purchases

365

1695

1.22

3.19

1.1

6.47

5.55

u/ml

0.20

143

744

Hypothyroidism and >3 levothyroxin purchases

365

1695

1.22

3.19

1.1

6.47

5.55

u/ml

0.20

143

744

Disorders of choroid and retina

320

2781

0.82

3.18

1.1

3.53

3.98

u/ml

0.20

129

1106

Rosacea

595

1.49

3.18

1.1

7.24

3.34

u/ml

0.98

216

Covid-19 confirmed case

236

1864

1.27

3.17

1.1

6.18

5.06

u/ml

0.32

112

796

Stomatitis and related lesions

165

1244

1.33

3.17

1.1

3.13

5.87

u/ml

1.99

528

Coronary artery bypass grafting

283

0.42

3.15

1.1

1.0

1.26

2.74

u/ml

—

103

Lateral epicondylitis

678

1.45

3.15

1.1

3.09

3.47

u/ml

0.11

236

Retinal breaks without detachment

507

1.52

3.14

1.1

1.75

2.71

u/ml

0.58

190

Other diseases of stomach and duodenum

158

1.97

3.14

1.1

5.91

3.44

u/ml

0.20

Dementia

401

0.53

3.13

1.0

1.1

1.51

1.87

u/ml

0.10

160

Non-rheumatic valve diseases

134

1314

0.73

3.13

1.1

2.75

4.84

u/ml

1.35

529

Seborrhoeic dermatitis

335

1.65

3.12

1.1

1.0

2.72

2.90

u/ml

0.05

116

Tinnitus

139

1026

1.36

3.07

1.1

1.0

6.49

3.27

u/ml

0.69

392

Bacterial infection, other or unspecified

214

2297

0.79

3.07

1.1

4.37

4.72

u/ml

0.12

930

Injury of muscle and tendon at lower leg level

682

1.44

3.06

1.0

1.1

2.58

3.89

u/ml

0.79

269

Separation of retinal layers (serosa)

160

1.96

3.05

1.1

2.66

4.92

u/ml

0.63

Other viral hepatitis

466

0.49

3.05

1.2

1.1

9.02

4.19

u/ml

0.43

187

Menorrhagia

291

1301

1.24

3.05

1.1

3.39

4.83

u/ml

0.69

116

528

Fracture of femur

532

0.54

3.04

1.0

1.1

2.81

4.52

u/ml

—

224

Explicit Sepsis

154

1898

0.76

3.02

1.1

5.58

5.07

u/ml

0.12

793

Convergence insufficiency and excess

2.39

3.02

1.2

1.1

4.27

6.88

u/ml

0.35

Hypothyroidism, strict autoimmune, 3 medication purchases required

690

4067

1.15

3.01

1.1

5.10

5.12

u/ml

0.01

262

1677

Injuries to the ankle and foot

701

5458

1.14

3.01

1.1

5.87

5.46

u/ml

0.21

323

2327

Other diseases of the respiratory system

488

1.52

3.01

1.1

1.80

4.26

u/ml

2.11

202

Other respiratory disorders and diseases

488

1.52

3.01

1.1

1.80

4.26

u/ml

2.11

202

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

485

2620

1.18

2.99

1.1

4.11

6.03

u/ml

1.66

218

1080

Extrapyramidal and movement disorders

176

1350

1.31

2.99

1.1

4.83

3.47

u/ml

0.36

522

Abnormal findings in secretions and smears from cervix uteri vagina vulva

511

3304

1.17

2.98

1.0

1.1

3.88

4.85

u/ml

0.65

191

1319

Malaise and fatigue

344

2289

1.21

2.98

1.1

4.37

4.92

u/ml

0.22

154

977

Other intervertebral disc disorders

643

3362

1.15

2.96

1.0

1.1

5.30

4.19

u/ml

0.43

262

1353

Dysplasia of cervi uteri

252

1459

1.25

2.96

1.0

1.1

3.78

5.18

u/ml

0.74

609

Implicit bacterial Sepsis

1153

0.70

2.96

1.0

1.1

3.50

3.68

u/ml

0.05

442

Nephropathy related operations

475

0.50

2.96

1.0

1.1

4.56

4.80

u/ml

0.02

208

Rotator cuff syndrome

360

2143

1.21

2.95

1.0

1.1

1.77

3.62

u/ml

3.47

140

793

Pre-eclampsia or poor fetal growth

232

2885

0.80

2.94

1.1

4.04

5.03

u/ml

0.42

1162

Type 1 diabetes, strict definition, subgroup 1

910

0.64

2.94

1.1

8.47

6.03

u/ml

0.39

427

Other/unspecified synovitis and tenosynovitis

548

1.49

2.94

1.0

1.1

6.98

3.90

u/ml

0.39

209

Heart failure,strict

986

0.71

2.94

1.1

1.0

5.43

3.59

u/ml

0.25

388

Bleeding

375

3185

0.84

2.94

1.1

4.52

4.84

u/ml

0.13

167

1313

Heart failure and antihypertensive medication

658

0.65

2.93

1.1

7.21

4.08

u/ml

0.32

257

Other abnormal products of conception

417

2324

1.19

2.92

1.1

4.74

4.96

u/ml

0.08

160

913

Patellar tendinitis

2.25

2.92

1.0

1.1

18.52

7.76

u/ml

0.51

Heart failure, strict

102

1009

0.71

2.92

1.1

1.0

5.19

3.46

u/ml

0.25

402

malignant neoplasm of male genital organs

440

0.59

2.90

1.0

0.30

2.57

u/ml

3.83

174

Disorders of muscles

485

1.51

2.90

1.1

1.0

3.77

4.37

u/ml

0.15

178

L02BG Aromatase inhibitors

1078

0.67

2.89

1.1

1.81

3.59

u/ml

1.46

397

Hypothyroidism (congenital or acquired)

366

1718

1.21

2.89

1.1

6.42

5.50

u/ml

0.20

146

759

Lichen planus, including avohilmo

682

1.43

2.88

1.0

1.1

5.68

3.09

u/ml

0.42

247

Faecal incontinence

236

1.74

2.88

1.0

0.98

3.48

u/ml

1.77

Unspecified event, undetermined intent

136

2.01

2.87

1.1

5.71

5.55

u/ml

0.02

Polyarteritis nodosa and related conditions

3.21

2.86

1.1

0.58

2.97

u/ml

—

Chondropathies

129

954

1.36

2.86

1.0

1.1

6.20

4.83

u/ml

0.27

383

Lichen ruber planus, wide definition including periferal and oral lichen planus

114

826

1.38

2.86

1.0

1.1

5.05

3.07

u/ml

0.37

302

Mental and behavioural disorders due to cannabinoids

288

0.38

2.84

1.1

17.63

6.06

u/ml

—

126

Congenital malformations, deformations and chromosomal abnormalities

649

5237

1.14

2.84

1.0

1.1

5.07

5.70

u/ml

0.41

295

2233

All-cause Heart Failure

100

987

0.71

2.82

1.1

1.0

2.88

3.40

u/ml

0.10

389

Diseases of oral cavity, salivary glands and jaws

409

1767

1.19

2.81

1.1

4.65

4.83

u/ml

0.06

168

700

Persons with potential health hazards related to communicable diseases

455

3857

1.17

2.80

1.1

6.77

6.13

u/ml

0.26

219

1733

Embedded and impacted teeth

386

2684

1.19

2.79

1.1

8.51

6.33

u/ml

0.64

187

1249

Hypersensitivity pneumonitis due to organic dust

3.12

2.78

1.1

0.52

4.13

u/ml

—

Noninfectious colitis NAS

106

763

1.40

2.78

1.1

3.36

4.72

u/ml

0.58

329

Herpesviral [herpes simplex] infections

630

1.44

2.77

1.1

10.05

4.23

u/ml

1.28

252

Hard cardiovascular diseases

425

2981

0.85

2.76

1.1

2.90

4.65

u/ml

1.47

160

1199

Deforming dorsopathies

204

1615

1.27

2.75

1.0

1.1

6.54

5.56

u/ml

0.14

666

Endometriosis

317

1532

1.22

2.75

1.1

2.57

5.63

u/ml

3.56

135

648

Chronic kidney disease

752

0.62

2.75

1.0

1.1

7.71

3.96

u/ml

0.48

314

Inflammatory disease of uterus

147

1117

1.32

2.74

1.1

3.83

4.85

u/ml

0.26

460

Rheumatism, unspecified

549

1.46

2.73

1.1

1.0

1.32

3.12

u/ml

1.52

186

Viral hepatitis

499

0.54

2.72

1.1

9.02

4.11

u/ml

0.44

200

Asymmetry of jaw

105

2.14

2.72

1.1

4.14

6.13

u/ml

0.29

Myotonic disorders

3.53

2.71

1.2

1.1

1.53

5.54

u/ml

—

Other congenital malformations of skin

264

1.69

2.71

1.1

7.62

6.71

u/ml

0.14

129

Reimbursement for rheumatic diseases

286

3445

0.82

2.70

1.0

1.1

3.07

4.82

u/ml

1.42

115

1422

Kidney transplant status

267

0.37

2.70

1.0

1.1

23.63

6.56

u/ml

—

123

Atrial fibrillation and flutter

134

1153

0.75

2.69

1.0

1.80

4.15

u/ml

2.88

426

Foreign body in alimentary tract

234

1.72

2.69

1.1

3.47

5.94

u/ml

0.57

106

Certain infectious and parasitic diseases

945

4236

1.12

2.68

1.1

4.88

5.44

u/ml

0.40

415

1791

Benign neoplasm of eye and adnexa

326

1.60

2.68

1.0

1.1

1.45

4.58

u/ml

2.28

129

Dislocation, sprain and strain of joint and ligaments of hip

2.19

2.67

1.1

5.44

4.50

u/ml

—

Other obstetric conditions, not elsewhere classified

487

2664

1.17

2.67

1.1

4.21

5.96

u/ml

1.44

217

1095

Other disorders of white blood cells

190

1.80

2.67

1.2

1.0

0.95

5.63

u/ml

2.52

Monoplegia

2.83

2.66

1.0

1.1

0.32

2.96

u/ml

—

Type 1 diabetes, strict definition

946

0.67

2.64

1.1

9.21

6.18

u/ml

0.52

443

Disturbance of activity and attention

192

1491

1.27

2.62

1.1

12.05

7.48

u/ml

0.80

745

Postmenopausal atrophic vaginitis

132

541

1.35

2.61

1.0

3.25

3.35

u/ml

0.03

192

Anogenital herpesviral [herpes simplex] infection

132

997

1.33

2.60

1.1

4.47

5.80

u/ml

0.39

433

Combinations of oral blood glucose lowering drugs

888

0.66

2.59

1.1

1.0

5.02

3.06

u/ml

0.22

322

Fissure and fistula of anal and rectal regions

161

1249

1.29

2.58

1.1

4.90

3.90

u/ml

0.23

504

Urticaria due to cold and heat

2.79

2.57

1.1

1.0

9.90

6.86

u/ml

—

Otitis media, unspecified

149

1054

1.31

2.57

1.2

1.1

11.26

8.62

u/ml

0.34

517

Certain disorders involving the immune mechanism

128

963

1.33

2.57

1.1

3.11

4.26

u/ml

0.44

387

Bacterial infection, other or unspecified

182

1994

0.79

2.57

1.0

1.1

3.74

4.21

u/ml

0.15

811

Hallux rigidus

378

1.54

2.55

1.1

4.08

3.24

u/ml

0.22

130

Other disorders of eye and adnexa

117

870

1.35

2.55

1.1

5.41

4.57

u/ml

0.17

353

Abrasion of teeth

235

1911

1.23

2.54

1.1

2.62

3.66

u/ml

0.88

111

734

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

327

2443

1.20

2.53

1.1

10.20

6.92

u/ml

0.89

151

1185

Mental retardation, wide definition

378

0.49

2.51

1.2

1.1

5.53

8.89

u/ml

—

206

Persons encountering health services in other circumstances, wide

1019

4736

1.11

2.51

1.1

5.71

5.22

u/ml

0.25

445

2005

Uterine polyps

404

1.52

2.50

1.0

1.1

6.16

3.42

u/ml

0.31

151

Other viral diseases, not elsewhere classified

185

1464

1.27

2.50

1.1

11.59

6.29

u/ml

1.35

658

LeFortI or BSSO operation

294

1.62

2.49

1.1

1.56

5.77

u/ml

2.82

119

All influenza

176

1388

1.27

2.49

1.1

2.14

5.54

u/ml

3.19

600

Chronic viral hepatitis

406

0.51

2.49

1.1

9.02

4.31

u/ml

0.42

168

Benign neoplasm: Choroid

158

1.85

2.48

1.0

1.1

0.41

3.99

u/ml

2.11

Bruxism

116

2.01

2.48

1.0

1.1

2.00

2.85

u/ml

—

Malignant neoplasm of skin

132

1186

0.76

2.47

1.0

1.1

3.01

2.98

u/ml

0.01

448

Nonorganic sleeping disorders, excluding more controls

191

1524

1.26

2.47

1.1

4.19

4.69

u/ml

0.21

637

Benign neoplasm: Ascending colon

294

1.60

2.47

1.1

4.24

2.45

u/ml

0.28

113

Other diseases of intestines

1011

5199

1.11

2.46

1.1

4.89

5.56

u/ml

0.48

389

2286

Toxic effect of contact with venomous animals

218

1.71

2.46

1.0

1.1

7.19

5.17

u/ml

0.20

Exophthalmic conditions

3.18

2.45

1.0

1.14

8.58

u/ml

—

Carpal tunnel syndrome

402

3033

1.17

2.45

1.1

4.60

3.64

u/ml

0.23

146

1199

Injuries to the knee and lower leg

1047

5265

1.10

2.44

1.1

5.75

5.19

u/ml

0.25

457

2224

Disorders of breast

407

3169

1.17

2.43

1.1

5.37

4.88

u/ml

0.19

154

1266

Other superficial mycoses

104

766

1.37

2.43

1.1

4.30

5.27

u/ml

0.28

326

Lumbar disc prolapse

466

3092

1.16

2.43

1.0

1.1

4.61

4.00

u/ml

0.26

202

1244

Benign neoplasm: Scapula and long bones of upper limb

2.95

2.43

1.0

1.1

1.42

4.26

u/ml

—

Mixed conductive and sensorineural hearing loss

319

1.57

2.43

1.0

1.1

1.88

3.16

u/ml

0.83

129

638

1.38

2.42

1.1

1.0

2.41

2.76

u/ml

0.09

242

Other retinal disorders

209

2011

0.81

2.42

1.1

3.45

3.70

u/ml

0.09

813

Atherosclerosis, excluding cerebral and coronary sclerosis

560

0.64

2.41

1.1

1.0

1.18

2.47

u/ml

1.19

213

Single spontaneous delivery

244

1576

0.82

2.40

1.1

5.72

6.53

u/ml

0.25

117

701

Endometriosis ASRM stages 1,2

175

1388

1.27

2.40

1.1

2.53

4.66

u/ml

1.55

556

Other disorders starting during childhood or adolecense, excluding more controls

606

1.41

2.39

1.1

8.66

8.09

u/ml

0.07

320

Medicines for HER+ breast cancer

124

1539

0.76

2.39

1.1

1.81

3.56

u/ml

2.26

559

Hypoplasia of dental enamel, prenatal

0.00

2.38

0.0

1.2

—

7.79

—

Disorders of orbit

183

1.76

2.36

1.0

1.1

1.91

4.28

u/ml

0.83

Panic disorder

175

1391

1.26

2.36

1.1

3.94

5.19

u/ml

0.54

600

Other congenital malformations of skin

534

1.43

2.35

1.1

5.99

5.55

u/ml

0.09

230

Insulin, fast-acting (human)

1055

0.71

2.34

1.1

6.37

4.62

u/ml

0.38

446

Genitourinary diseases

580

2552

1.14

2.34

1.1

6.80

6.31

u/ml

0.17

247

1194

Perforation of tympanic membrane

493

1.45

2.34

1.1

6.34

6.46

u/ml

0.02

203

Stenosis and insufficiency of lacrimal passages

323

1.55

2.32

1.1

5.15

3.67

u/ml

0.24

130

Other acute skin changes due to ultraviolet radiation

105

2.02

2.31

1.1

1.0

1.19

4.67

u/ml

1.25

Other demyelinating diseases of the central nervous system

275

0.43

2.31

1.1

4.17

4.61

u/ml

—

103

Persons encountering health services in circumstances related to reproduction

577

3424

1.14

2.30

1.1

5.72

6.16

u/ml

0.18

246

1523

Urethritis and urethral syndrome

2.14

2.30

1.2

1.1

1.43

5.03

u/ml

—

Glaucoma suspect

140

1086

1.29

2.28

1.1

3.15

3.00

u/ml

0.03

418

Mental retardation

364

0.51

2.27

1.2

1.1

5.53

8.90

u/ml

—

200

Metatarsalgia

463

1.45

2.27

1.1

5.25

2.99

u/ml

0.39

169

Deep bite that required surgery

2.31

2.26

1.0

1.1

2.62

4.05

u/ml

—

Polyp of the female genital tract

222

1037

1.23

2.26

1.1

3.33

3.42

u/ml

0.03

416

Hyperkinetic disorders

200

1590

1.24

2.26

1.1

11.97

7.43

u/ml

0.86

794

All influenza (not pneumonia)

117

888

1.32

2.26

1.1

1.19

5.19

u/ml

6.82

378

Finngen Rheumatological endpoints

751

4760

0.90

2.24

1.1

3.23

5.46

u/ml

4.27

310

1994

Chronic suppurative otitis media, including avohilmo

440

1.46

2.24

1.1

4.35

6.14

u/ml

0.49

202

COPD, hospital admissions 3, with asthma pneumonia sepsis

367

1.47

2.22

1.1

1.0

5.85

2.44

u/ml

0.50

143

Disorders of gallbladder, biliary tract and pancreas

567

4042

0.88

2.21

1.1

3.47

4.42

u/ml

0.72

218

1624

Other complications of surgical and medical care, not elsewhere classified

483

1.44

2.20

1.2

1.1

1.86

4.02

u/ml

1.35

183

Viral conjunctivitis

234

1.64

2.18

1.1

4.66

5.72

u/ml

0.22

Other and unspecified disorders of vitreous body

162

1271

1.26

2.17

1.0

1.1

2.30

3.28

u/ml

0.45

454

Trigger finger

627

1.38

2.17

1.1

1.0

3.66

3.27

u/ml

0.07

221

Disorders of refraction and accommodation

262

2185

1.20

2.17

1.1

7.39

6.55

u/ml

0.13

112

976

Other symptoms and signs involving the digestive system and abdomen

103

773

1.34

2.16

1.1

1.0

2.37

4.92

u/ml

1.56

327

Contracture of joint

2.81

2.15

1.0

6.43

5.21

u/ml

—

Redundant prepuce, phimosis and paraphimosis

144

1122

1.27

2.13

1.0

7.12

5.57

u/ml

0.32

534

Suppurative otitis media, unspecified

152

1.80

2.13

1.0

1.1

12.89

6.93

u/ml

0.32

Factors influencing health status and contact with health services

248

1029

1.21

2.12

1.1

1.0

4.89

5.52

u/ml

0.22

110

375

Abnormal findings on diagnostic imaging of central nervous system

236

1.62

2.11

1.0

1.1

2.11

5.94

u/ml

1.95

Injuries to the neck

200

1637

1.23

2.10

1.1

7.82

5.49

u/ml

0.59

691

Oxycodone

1144

0.75

2.10

1.1

1.0

4.77

3.54

u/ml

0.19

444

Shoulder lesions

506

2694

1.14

2.09

1.0

1.1

2.30

3.88

u/ml

2.51

188

1045

Complications predominantly related to the puerperium

259

2175

1.19

2.09

1.1

4.12

5.07

u/ml

0.31

104

885

Seropositive rheumatoid arthritis, strict definition

595

0.64

2.09

1.1

0.56

3.41

u/ml

5.13

216

Superficial injury of hip and thigh

555

1.39

2.08

1.1

6.09

4.64

u/ml

0.34

228

Dental operations

412

1831

1.16

2.08

1.0

1.1

4.84

5.06

u/ml

0.07

165

727

Other enthesopathy of foot (+metatarsalgia)

514

1.41

2.07

1.1

5.07

3.26

u/ml

0.31

187

Other benign neoplasms of uterus

2.08

2.07

1.1

5.73

1.62

u/ml

—

Sarcoidosis

565

1.39

2.06

1.1

3.98

3.23

u/ml

0.15

210

Complications associated with artificial fertilization

154

1.78

2.06

1.0

1.1

9.38

4.03

u/ml

0.67

Malignant neoplasm of respiratory system and intrathoracic organs

297

0.53

2.06

1.0

1.1

0.04

2.79

u/ml

—

112

Other and unspecified corneal deformities and disorders

139

1.81

2.06

1.0

1.1

10.76

4.13

u/ml

0.79

Immunodeficiency with predominantly antibody defects

132

1.84

2.05

1.0

1.1

1.61

6.81

u/ml

1.99

Malignant neoplasm of bronchus and lung, including Hilmo

297

0.53

2.03

1.1

1.52

2.26

u/ml

—

112

Ulcer of vagina/vulva

140

1.81

2.02

1.2

1.1

15.69

7.40

u/ml

—

Any operation in hilmo

171

1.53

2.02

1.1

1.0

5.25

5.79

u/ml

0.07

Postdysenteric arthropathy

2.68

2.02

1.2

1.0

4.51

5.78

u/ml

—

Viral pneumonia (unknown virus, not influenza)

335

1.50

2.01

1.1

13.81

4.77

u/ml

0.95

139

Polyuria

739

1.33

2.01

1.1

2.19

3.48

u/ml

0.81

294

Endometriosis of rectovaginal septum and vagina

368

1.48

2.00

1.1

1.05

3.42

u/ml

2.53

141

Contact with and exposure to communicable diseases

395

3429

1.15

2.00

1.1

7.37

6.16

u/ml

0.49

183

1550

Injury of muscle and tendon at shoulder and upper arm level

157

1259

1.25

2.00

1.1

1.0

3.41

3.45

u/ml

0.01

465

Hernia of abdominal wall

255

2147

1.19

2.00

1.0

1.1

3.28

3.87

u/ml

0.33

111

853

Other disorders of breast

749

1.33

2.00

1.0

1.1

4.18

4.06

u/ml

0.02

289

Haemangioma and lymphangioma, any site

451

1.43

2.00

1.1

7.50

4.36

u/ml

0.46

190

Implicit viral Sepsis

161

1296

1.24

1.98

1.1

5.35

4.99

u/ml

0.10

530

Fracture at wrist and hand level

273

2312

1.18

1.97

1.1

8.38

5.13

u/ml

0.90

132

1003

Other spirochaetal diseases

180

1469

1.23

1.97

1.1

3.95

3.99

u/ml

0.01

584

Contraceptive management

412

2522

1.15

1.96

1.1

5.16

5.40

u/ml

0.08

160

1046

Obesity

539

4629

1.13

1.96

1.1

5.58

4.91

u/ml

0.21

231

1878

Suicide or other Intentional self-harm

149

1853

0.80

1.96

1.1

5.93

5.79

u/ml

0.03

782

Alcoholic liver disease

270

0.48

1.95

1.1

1.0

16.33

3.13

u/ml

—

106

Demyelinating diseases of the central nervous system

620

0.66

1.95

1.0

1.1

2.49

3.44

u/ml

0.28

251

Thyroiditis

379

1.46

1.94

1.0

1.1

17.68

4.46

u/ml

0.40

151

Other bacterial intestinal infections

132

1042

1.27

1.94

1.1

3.10

5.04

u/ml

0.72

428

Hypertensive diseases (excluding secondary)

431

2853

0.88

1.94

1.1

3.54

4.61

u/ml

0.78

182

1174

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

400

3485

1.15

1.93

1.1

5.69

5.77

u/ml

0.03

176

1538

Other bursopathies

463

1.41

1.92

1.1

4.25

3.58

u/ml

0.11

169

Disorders of ocular muscles, binocular movement, accommodation and refraction

431

3760

1.14

1.91

1.1

6.42

5.94

u/ml

0.12

197

1649

Atrial septal defect

317

0.53

1.91

1.1

5.42

9.06

u/ml

—

171

Irregular menses

511

3584

1.13

1.91

1.1

3.75

5.63

u/ml

1.68

202

1459

Other abnormal uterine and vaginal bleeding

146

833

1.26

1.91

1.1

2.21

5.04

u/ml

1.93

341

Keratoconus

128

1.82

1.91

1.1

15.55

3.45

u/ml

1.19

Pedestrian injured in collision with pedal cycle

128

1.81

1.90

1.0

1.1

2.85

4.85

u/ml

0.58

Measles

2.19

1.90

1.1

1.0

9.90

3.65

u/ml

—

Intermittent heterotropia

542

0.64

1.89

1.1

23.52

6.99

u/ml

0.45

281

Obesity and other hyperalimentation

539

4635

1.12

1.89

1.1

5.58

4.92

u/ml

0.21

231

1882

Infections with a predominantly sexual mode of transmission

334

2888

1.16

1.89

1.1

4.58

5.37

u/ml

0.35

134

1237

Inflammation of lacrimal passages (acute and unspecified)

2.33

1.88

1.2

1.1

0.23

5.24

u/ml

—

Infections of the skin and subcutaneous tissue

482

4235

1.13

1.88

1.1

8.33

5.28

u/ml

1.37

224

1850

Other specified/unspecified soft tissue disorders

136

1.77

1.87

1.0

10.21

3.17

u/ml

—

Haemangioma, any site

399

1.44

1.86

1.1

7.33

4.73

u/ml

0.31

173

Arthropod-borne viral fevers and viral haemorrhagic fevers

117

915

1.28

1.86

1.1

4.43

4.94

u/ml

0.16

388

Hypertension, essential

506

3222

0.89

1.86

1.1

3.39

4.06

u/ml

0.47

206

1245

Implicit bacterial Sepsis

117

1284

0.79

1.85

1.1

4.05

3.79

u/ml

0.07

498

Viral haemorrhagic fevers, not elsewhere classified/unspecified

107

828

1.30

1.85

1.1

4.23

5.03

u/ml

0.25

358

Other systemic involvement of connective tissue (FG)

149

1185

1.24

1.85

1.1

3.46

4.63

u/ml

0.38

458

Superficial injury of lower leg

200

1663

1.21

1.84

1.1

9.34

5.47

u/ml

0.61

712

Other/unspecified dorsalgia

253

2131

1.18

1.82

1.1

3.40

4.60

u/ml

0.90

117

870

Haemorrhage in early pregnancy

274

2282

1.17

1.82

1.1

1.0

3.42

5.07

u/ml

1.35

107

914

Acute pancreatitis

764

0.71

1.82

1.1

1.0

2.16

4.09

u/ml

1.35

290

Nonorganic sleeping disorders

191

1584

1.21

1.82

1.1

4.19

5.70

u/ml

0.77

679

Acute epiglottitis

2.29

1.81

1.2

1.1

1.09

2.81

u/ml

—

Malignant neoplasm of breast, ER-negative, including Hilmo

794

0.72

1.81

1.0

1.1

4.16

2.95

u/ml

0.21

294

Benign paroxysmal vertigo

138

1106

1.25

1.81

1.0

1.1

2.71

3.28

u/ml

0.21

417

Diseases of arteries, arterioles and capillaries (FINNGEN)

786

0.76

1.81

1.1

1.0

2.46

4.02

u/ml

0.67

284

Mental retardation, excluding more controls

329

0.56

1.80

1.2

1.1

5.53

9.29

u/ml

—

179

Cellulitis

154

1250

1.24

1.80

1.1

7.80

4.48

u/ml

0.91

521

Exposure to other and unspecified animate mechanical forces

223

1.59

1.80

1.1

3.75

5.98

u/ml

0.57

Outcome of delivery

167

1260

0.82

1.80

1.0

1.1

3.39

6.39

u/ml

1.78

519

Oter anti-inflammatory and antirheumatic agents, non-steroids

315

1.37

1.80

1.1

2.03

2.84

u/ml

0.37

143

Other systemic involvement of connective tissue

149

1205

1.24

1.80

1.1

3.46

4.75

u/ml

0.43

474

Other appendicitis

419

1.41

1.79

1.1

4.33

3.96

u/ml

0.05

163

Other and unspecified polyneuropathies, also in other diseases

486

1.38

1.79

1.1

1.0

4.92

3.70

u/ml

0.22

189

Other/unspecified enthesopathies, not elsewhere classified

295

1.50

1.79

1.2

1.1

6.40

3.84

u/ml

0.19

109

Foreign body entering into or through eye or natural orifice

453

1.40

1.79

1.0

1.1

3.72

5.12

u/ml

0.50

195

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

161

1.68

1.78

1.0

1.1

13.82

4.27

u/ml

—

Coronary atherosclerosis

191

1455

0.83

1.78

1.0

2.23

3.29

u/ml

0.87

544

Open wound of wrist and hand

364

3115

1.14

1.76

1.1

6.46

4.97

u/ml

0.66

157

1331

Other spirochaetal diseases

183

1516

1.21

1.76

1.1

3.94

4.01

u/ml

0.02

607

Benign neoplasm of bone and articular cartilage

455

1.39

1.75

1.0

1.1

2.12

5.29

u/ml

2.21

184

Cervicobrachial syndrome

145

1175

1.24

1.74

1.1

9.00

3.58

u/ml

0.62

441

Presence of other devices

633

1.32

1.73

1.1

1.0

2.56

3.62

u/ml

0.34

237

Thyroiditis, ILD-related definition

741

1.30

1.73

1.1

10.27

3.67

u/ml

0.33

288

Maternal care for other known or suspected fetal problems

258

1909

0.85

1.73

1.1

5.23

6.25

u/ml

0.34

103

796

Delivery

257

1589

0.85

1.72

1.1

5.18

6.50

u/ml

0.47

119

708

Transient ischemic attack

118

1201

0.79

1.72

1.1

1.0

2.01

3.02

u/ml

0.74

447

Colonic or urogenital fistula

163

1339

1.22

1.72

1.1

4.76

3.83

u/ml

0.22

540

Synovial cyst of popliteal space [Baker]

202

1.59

1.71

1.1

1.0

4.48

3.26

u/ml

0.12

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

118

1.79

1.70

1.1

4.56

4.95

u/ml

—

Budesonide

760

1.29

1.70

1.0

1.1

3.42

4.06

u/ml

0.18

282

Myopia

133

1072

1.25

1.69

1.1

6.17

5.88

u/ml

0.05

461

Seropositive rheumatoid arthritis

1013

0.76

1.69

1.0

1.1

1.17

3.38

u/ml

3.25

375

Other disorders of Eustachian tube

126

1.76

1.68

1.1

0.80

5.89

u/ml

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

110

1385

0.79

1.68

1.1

7.02

5.72

u/ml

0.25

583

Status post-ami

330

0.62

1.67

1.0

0.49

2.54

u/ml

—

121

Panniculitis affecting regions of neck and back

149

1.69

1.67

1.1

2.10

3.26

u/ml

—

Acute pancreatitis (for exclusion)

751

0.72

1.67

1.1

2.16

3.91

u/ml

1.17

292

Haemorrhoids and perianal venous thrombosis

150

1223

1.23

1.67

1.0

1.1

3.87

3.30

u/ml

0.13

495

General examination and investigation of persons without complaint and reported diagnosis

529

2472

1.12

1.66

1.1

1.0

6.42

5.77

u/ml

0.19

236

985

Special screening examination for neoplasms

157

1.66

1.65

1.0

3.30

1.27

u/ml

—

Dyshidrosis [pompholyx]

2.00

1.65

1.0

1.1

2.52

6.84

u/ml

—

Major coronary heart disease event excluding revascularizations

154

1250

0.82

1.65

1.1

1.0

1.30

2.86

u/ml

2.50

471

malignant neoplasm of female genital organs

451

0.64

1.65

1.0

1.1

2.06

3.55

u/ml

0.78

167

Acute alcohol intoxication, ICD10

1215

0.78

1.65

1.1

7.63

5.55

u/ml

0.42

496

Superficial injury of wrist and hand

192

1612

1.19

1.64

1.1

6.65

5.77

u/ml

0.17

709

Later onset COPD

174

1.56

1.63

1.0

0.77

1.65

u/ml

0.75

Acute lymphadenitis

411

1.40

1.63

1.1

5.90

5.19

u/ml

0.13

172

Rheumatoid arthritis, including avohilmo

139

1701

0.82

1.63

1.1

2.09

3.69

u/ml

1.31

653

Other hammer toe(s) (acquired)

370

1.40

1.62

1.1

1.0

3.10

2.41

u/ml

0.20

128

Tramadol

581

3222

1.11

1.62

1.1

1.0

3.49

4.35

u/ml

0.55

253

1312

Benign intracranial hypertension

1.94

1.62

1.1

4.29

7.21

u/ml

—

Congenital malformations of the respiratory system

128

1.74

1.61

1.1

0.98

8.75

u/ml

3.58

Other and specified injuries of hip and thigh

2.16

1.61

1.2

1.1

0.84

6.38

u/ml

—

MS-disease / Multiple Sclerosis

534

0.67

1.61

1.0

1.1

2.89

3.34

u/ml

0.10

221

Postmenopausal bleeding

110

460

1.28

1.61

1.0

1.59

2.90

u/ml

1.00

162

Bilateral sagittal split ramus osteotomy operation

246

1.52

1.61

1.1

1.67

5.56

u/ml

2.30

100

Other and unspecified visual disturbances

437

1.38

1.61

1.2

1.1

3.56

4.01

u/ml

0.13

173

Immunodeficiencies

246

1.51

1.60

1.1

1.12

7.29

u/ml

4.22

104

Malignant neoplasm of prostate

351

0.68

1.60

1.0

0.32

2.71

u/ml

2.85

134

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

974

0.76

1.60

1.0

1.1

1.20

3.47

u/ml

3.10

355

Other acquired deformities of musculoskeletal system and connective tissue

190

1.59

1.60

1.0

1.1

2.41

3.24

u/ml

—

Injury of muscle and tendon at hip and thigh level

446

1.37

1.60

1.1

4.12

4.57

u/ml

0.06

170

Congenital malformations, deformations and chromosomal abnormalities

585

5050

1.10

1.60

1.0

1.1

5.30

5.71

u/ml

0.22

269

2176

Oral lichen planus

2.01

1.59

1.0

1.1

7.99

3.23

u/ml

—

Use of pramipexole

715

1.29

1.59

1.1

1.79

3.07

u/ml

1.09

266

False labour

393

2168

1.13

1.59

1.1

4.19

6.21

u/ml

1.54

167

878

Generalized skin eruption due to drugs and medicaments

175

1.61

1.58

1.0

1.1

5.79

5.91

u/ml

0.01

Poor fetal growth

107

1339

0.80

1.57

1.1

3.78

4.94

u/ml

0.32

551

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

1.56

0.0

1.1

—

4.20

—

Other/unspecified seropositive rheumatoid arthritis

981

0.76

1.56

1.0

1.1

1.20

3.45

u/ml

3.08

358

Biological medication for rheuma

108

1349

0.80

1.56

1.0

1.1

4.38

5.66

u/ml

0.40

559

Postpartum care and examination

157

1199

0.83

1.56

1.1

5.74

7.29

u/ml

0.44

502

Viral conjunctivitis

122

1.74

1.55

1.1

7.36

6.02

u/ml

—

Tetralogy of Fallot, a congenital heart defect.

0.00

1.55

0.0

1.1

—

11.17

—

Other reaction to severe stress, and adjustment disorders

368

3260

1.13

1.55

1.1

7.19

4.97

u/ml

1.06

165

1368

Rheumatoid arthritis

120

1330

0.81

1.55

1.1

2.01

3.61

u/ml

1.10

475

Ischaemic heart disease, wide definition

279

1990

0.87

1.55

1.0

1.1

1.92

3.42

u/ml

2.05

761

Benign neoplasm: Colon

192

1546

1.19

1.55

1.1

1.0

3.57

3.24

u/ml

0.11

567

Pre-eclampsia or eclampsia

136

1656

0.82

1.54

1.1

3.91

4.14

u/ml

0.06

672

Juvenile osteochondrosis

249

1.50

1.53

1.0

1.1

4.93

7.11

u/ml

0.21

104

Seropositive rheumatoid arthritis, wide

1001

0.77

1.53

1.0

1.1

1.17

3.49

u/ml

3.36

367

Other/unspecified soft tissue disorders related to use, overuse and pressure

130

1.71

1.53

1.1

1.0

3.27

4.52

u/ml

—

Type1 diabetes, definitions combined, early onset

791

0.74

1.53

1.1

6.76

6.44

u/ml

0.05

373

Heart failure and coronary heart disease

599

0.74

1.53

1.1

1.0

4.43

3.28

u/ml

0.12

233

Muscle strain

161

1.63

1.53

1.1

1.0

4.52

3.57

u/ml

0.11

Other predominantly sexually transmitted diseases, not elsewhere classified

243

2096

1.16

1.52

1.1

4.88

5.61

u/ml

0.23

923

Impacted teeth

283

2194

1.15

1.52

1.1

8.91

7.09

u/ml

0.55

139

1031

Zoster [herpes zoster]

251

2134

1.16

1.52

1.0

1.1

4.07

4.60

u/ml

0.18

105

841

Wegener granulomatosis

0.00

1.52

0.0

1.0

—

4.51

—

Acute alcohol intoxication

111

1378

0.80

1.51

1.0

1.1

7.26

5.09

u/ml

0.51

550

Nausea and vomiting

175

1439

1.19

1.51

1.1

4.96

6.72

u/ml

0.56

662

Presence of cardiac and vascular implants and grafts

803

0.78

1.51

1.0

3.69

3.02

u/ml

0.09

324

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

443

0.65

1.51

1.1

3.09

4.10

u/ml

0.19

169

Inflammatory disorders of breast

495

1.34

1.50

1.0

1.1

5.50

4.23

u/ml

0.32

198

Lyme disease

172

1443

1.19

1.50

1.1

4.01

3.90

u/ml

0.03

570

Hyperplasia of prostate

119

541

1.25

1.50

1.0

0.83

3.01

u/ml

3.23

216

Congenital malformations of the respiratory system

116

1.75

1.50

1.2

1.1

0.98

8.49

u/ml

3.08

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

226

1.52

1.50

1.1

3.95

5.80

u/ml

0.40

Impingement syndrome of shoulder

115

927

1.24

1.49

1.1

1.0

3.46

3.49

u/ml

0.01

330

Coxarthrosis [arthrosis of hip](FG)

178

1487

0.84

1.49

1.1

1.53

3.37

u/ml

2.65

541

Post-traumatic stress disorder

105

839

1.26

1.49

1.1

7.85

5.50

u/ml

0.20

370

Retinal detachments and breaks

130

1062

1.23

1.49

1.1

4.24

3.25

u/ml

0.25

390

Poisoning by drugs, medicaments and biological substances

163

1943

0.84

1.49

1.1

9.92

5.63

u/ml

1.07

828

Pre-eclampsia

130

1582

0.82

1.48

1.0

1.1

4.18

4.20

u/ml

0.01

643

Ulcer of lower limb, not elsewhere classified

319

0.59

1.48

1.1

1.49

3.83

u/ml

1.01

127

Care involving dialysis

281

0.57

1.48

1.0

1.1

6.56

5.29

u/ml

—

123

Parkinson's disease, including avohilmo

230

0.52

1.48

1.0

0.40

1.87

u/ml

—

Other congenital malformations of the digestive system

416

1.37

1.48

1.1

6.98

8.08

u/ml

0.16

219

Streptococcal septicaemia

306

0.59

1.47

1.0

1.1

1.42

5.72

u/ml

—

138

Symptoms and signs involving cognition, perception, emotional state and behaviour

640

4770

0.91

1.47

1.1

5.00

4.96

u/ml

0.01

292

1966

Amblyopia ex anopsia

293

1.44

1.47

1.1

16.80

9.75

u/ml

0.30

150

Malignant neoplasm of breast, HER-negative

685

0.73

1.46

1.0

1.1

4.38

2.67

u/ml

0.30

254

Myocardial infarction

111

968

0.81

1.46

1.1

1.0

1.37

3.03

u/ml

1.91

359

Other heart diseases

407

2971

0.89

1.45

1.1

4.56

5.59

u/ml

0.49

171

1275

Monoamine oxidase A inhibitors

454

1.35

1.45

1.0

4.04

3.04

u/ml

0.17

171

Heterophoria

576

1.31

1.45

1.1

6.55

5.85

u/ml

0.12

267

Crossbite

720

1.27

1.45

1.1

7.22

8.01

u/ml

0.14

385

Other puerperal infections

103

825

1.26

1.44

1.1

8.07

4.32

u/ml

0.64

348

Disorders of thyroid, IBD co-morbidities

164

963

1.20

1.44

1.0

1.1

7.05

4.39

u/ml

0.28

413

Foreign body in respiratory tract

269

1.46

1.44

1.1

4.50

5.44

u/ml

0.15

123

L04AC Interleukin inhibitors

365

0.63

1.44

1.0

1.1

1.59

5.15

u/ml

2.39

148

Disorders of vestibular function (Vertigo)

227

1924

1.16

1.44

1.0

1.1

3.84

3.63

u/ml

0.07

737

Other diseases of liver

109

878

1.24

1.44

1.0

1.1

2.82

4.40

u/ml

0.64

340

Malignant neoplasm of prostate, including Hilmo

375

0.71

1.43

1.0

0.26

2.91

u/ml

3.71

144

Polyarthrosis

494

1.32

1.43

1.0

4.57

2.29

u/ml

0.27

163

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

341

3020

1.13

1.43

1.0

1.1

4.03

4.25

u/ml

0.08

147

1203

Spirochaetal infections, other/unspecified

173

1460

1.19

1.43

1.1

4.01

4.03

u/ml

0.01

577

Varicose veins of other sites

278

1.45

1.42

1.0

4.58

3.74

u/ml

0.16

119

Chronic suppurative otitis media

345

1.40

1.42

1.1

4.76

8.00

u/ml

0.73

150

413

0.66

1.41

1.1

5.70

10.35

u/ml

0.89

249

Disorders of lacrimal system and orbit in diseases classified elsewhere

103

1.76

1.41

1.0

1.1

0.13

4.08

u/ml

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

412

0.65

1.41

1.1

7.56

3.79

u/ml

0.28

163

Other arthrosis

301

1831

1.14

1.41

1.1

2.42

3.60

u/ml

1.14

130

662

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

562

3949

0.91

1.40

1.1

2.67

4.13

u/ml

2.48

225

1575

Melanocytic naevi

222

1916

1.16

1.40

1.0

1.1

5.91

4.88

u/ml

0.31

805

Atrial septal defect, secundum type

249

0.55

1.40

1.1

6.19

9.42

u/ml

—

136

Other congenital malformations of tongue, mouth and pharynx

221

1.51

1.40

1.1

6.98

9.15

u/ml

0.31

133

Benign neoplasm: Skin of eyelid, including canthus

492

1.32

1.40

1.1

9.65

3.57

u/ml

0.76

184

Other abnormal auditory perceptions

2.10

1.39

1.3

1.0

10.96

1.90

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

142

1.63

1.39

1.1

1.49

3.97

u/ml

1.18

Habitual aborter

190

1.54

1.39

1.0

1.1

3.00

3.60

u/ml

0.09

Other disorders of binocular movement

158

1.60

1.38

1.2

1.1

6.05

7.26

u/ml

0.15

371

0.64

1.38

1.2

1.1

5.67

10.47

u/ml

0.78

222

Viral infections characterized by skin and mucous membrane lesions

306

2701

1.13

1.38

1.1

6.53

5.37

u/ml

0.44

137

1179

Sequelae of injuries of upper limb

485

1.32

1.37

1.1

3.72

4.32

u/ml

0.17

199

Symptoms and signs involving the nervous and musculoskeletal systems

384

3438

1.12

1.37

1.1

6.55

5.06

u/ml

0.39

171

1472

Other noninflammatory disorders of vulva and perineum

555

1.30

1.37

1.1

6.93

4.07

u/ml

0.36

230

Meniscus derangement

350

2095

1.13

1.37

1.1

3.40

3.83

u/ml

0.18

147

780

Erosion of teeth , including avohilmo

232

2014

1.15

1.36

1.1

5.59

5.53

u/ml

0.01

110

860

Xanthelasma of eyelid

2.97

1.36

1.0

1.1

—

2.06

—

Leiomyosarcoma, including Hilmo

2.97

1.36

1.0

1.1

—

2.46

—

Concussion

448

3300

1.11

1.36

1.1

5.14

5.37

u/ml

0.10

205

1474

Benign neoplasm of middle ear and respiratory system

223

1.48

1.36

1.1

3.37

4.12

u/ml

0.17

Mental and behavioural disorders due to sedatives or hypnotics

431

0.67

1.35

1.0

1.1

5.39

5.47

u/ml

0.01

171

Other symptoms and signs involving the nervous and musculoskeletal systems

292

2576

1.14

1.35

1.1

7.03

5.06

u/ml

0.41

130

1083

Gonarthrosis [arthrosis of knee](FG)

367

2389

0.89

1.34

1.1

2.62

3.81

u/ml

1.14

150

887

Rash and other nonspecific skin eruption

452

1.33

1.34

1.1

5.89

4.84

u/ml

0.19

198

Other infective otitis externa

265

1.44

1.34

1.1

11.30

5.79

u/ml

0.45

110

Prolapse and hernia of ovary and fallopian tube

2.92

1.34

1.0

1.1

—

1.35

—

Giant cell arteritis with polymyalgia rheumatica

0.00

1.34

0.0

1.1

—

1.51

—

Glaucoma-related operations

1.87

1.34

1.0

1.1

0.65

2.53

u/ml

—

Fever of other and unknown origin

416

3334

1.11

1.34

1.1

5.03

5.31

u/ml

0.10

185

1455

Striae atrophicae

2.00

1.34

1.1

1.0

0.38

2.88

u/ml

—

Convulsions, not elsewhere classified

143

1683

0.84

1.34

1.1

8.23

6.20

u/ml

0.23

773

Fall on same level involving ice and snow

385

3456

1.12

1.33

1.0

1.1

7.24

4.90

u/ml

0.70

168

1438

Leiomyoma of uterus

376

2381

0.89

1.33

1.0

1.1

3.65

3.54

u/ml

0.04

130

904

Poisoning by medicine

148

1758

0.84

1.33

1.1

9.94

5.73

u/ml

0.95

753

Chronic apical periodontitis

835

5121

0.93

1.33

1.0

1.1

4.71

5.20

u/ml

0.34

356

2135

Invasive ventilation

284

0.60

1.33

1.1

0.65

4.89

u/ml

—

130

Speech and linguistic disorders, excluding more controls

109

835

1.23

1.33

1.1

6.87

7.59

u/ml

0.15

433

Major anomalies of jaw size

152

1.59

1.32

1.1

5.55

8.41

u/ml

0.30

Congenital malformations of cardiac septa

595

0.73

1.32

1.0

1.1

9.14

8.80

u/ml

0.04

306

Perineal laceration during delivery

173

1695

0.85

1.32

1.1

5.07

5.88

u/ml

0.25

700

Other congenital malformations

130

1079

1.21

1.31

1.1

5.00

6.31

u/ml

0.48

489

Nontraumatic intracranial haemmorrhage

452

0.68

1.31

1.1

5.64

3.33

u/ml

—

179

Other erythematous conditions

121

1.66

1.31

1.1

2.71

5.28

u/ml

—

Other complications of labour and delivery, not elsewhere classified

123

1359

0.83

1.30

1.0

1.1

9.20

6.19

u/ml

0.49

568

Other congenital malformations of circulatory system

106

1.71

1.30

1.1

1.0

4.48

4.22

u/ml

—

Atrial fibrillation and flutter with reimbursement

666

0.79

1.30

1.1

1.0

0.64

3.59

u/ml

4.72

240

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.91

1.29

1.1

26.51

6.01

u/ml

—

Impetigo

378

1.36

1.29

1.2

1.1

11.36

4.78

u/ml

1.61

179

Myocardial infarction, strict

101

886

0.81

1.29

1.1

1.0

1.34

2.84

u/ml

1.53

330

Radiculopathy

534

1.29

1.2

1.1

4.40

2.74

u/ml

0.26

192

Other specified/unspecified bacterial intestinal infections

226

1.47

1.28

1.1

4.41

4.01

u/ml

0.06

Other diseases of gallbladder

114

1.67

1.28

1.1

0.30

3.69

u/ml

—

Helminthiases

285

1.41

1.28

1.1

11.15

5.96

u/ml

0.54

122

Aplastic and other anaemias

126

1410

0.83

1.28

1.0

1.1

6.77

3.92

u/ml

0.86

573

Other, unspecified and serous retinal detachments

1.80

1.27

1.0

18.44

2.77

u/ml

—

Viral hepatitis, IBD co-morbidity

377

0.66

1.27

1.2

1.0

9.02

3.66

u/ml

0.49

160

L04AA Selective immunosuppressants

113

1368

0.82

1.26

1.0

1.1

3.81

4.61

u/ml

0.19

554

Infections of genitourinary tract in pregnancy

701

0.75

1.26

1.1

2.85

5.09

u/ml

1.01

290

Other disorders of binocular vision

1.84

1.26

1.0

1.1

5.44

6.80

u/ml

—

Spontaneous abortion

425

2589

1.11

1.26

1.1

3.69

4.82

u/ml

0.73

165

1033

Sequelae of injuries, of poisoning and of other consequences of external causes

158

1341

1.18

1.26

1.1

3.84

3.85

u/ml

0.00

535

Osteopathies and chondropathies

334

2780

1.12

1.26

1.0

1.1

4.39

5.00

u/ml

0.23

141

1141

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

204

0.54

1.26

1.0

2.37

4.17

u/ml

—

Sequelae of other external causes

219

1.47

1.26

1.1

2.53

5.55

u/ml

0.87

Other shoulder lesions

510

1.30

1.26

1.1

1.38

3.47

u/ml

1.69

195

Parkinson's disease

217

0.55

1.26

1.0

0.40

1.92

u/ml

—

Other disorders of veins

234

2035

1.14

1.25

1.1

1.0

2.82

3.66

u/ml

0.42

774

Pericarditis

115

1.66

1.25

1.1

1.0

1.17

4.47

u/ml

1.11

Generalized epilepsy, strict definition

179

1.52

1.24

1.0

1.1

8.72

8.31

u/ml

0.02

Postpartum hemorraghe, parous women as controls

286

2158

1.13

1.24

1.1

4.95

4.43

u/ml

0.16

105

849

Delivery, wide proxy

223

1360

0.87

1.24

1.1

6.11

7.04

u/ml

0.25

612

Sequelae of infectious and parasitic diseases

329

1.37

1.24

1.2

1.1

14.63

4.11

u/ml

0.82

122

Alopecia areata

155

1.56

1.23

1.0

1.1

13.22

7.86

u/ml

0.42

Examination and encounter for administrative purposes

131

1.61

1.23

1.1

1.0

9.82

3.49

u/ml

—

Antihypertensive medication - note that there are other indications

786

3869

1.08

1.23

1.1

7.05

6.01

u/ml

0.37

345

1727

Focal epilepsy

1187

0.81

1.22

1.1

6.46

5.40

u/ml

0.15

520

Non-selective monoamine reuptake inhibitors

187

1554

1.16

1.22

1.1

4.36

3.07

u/ml

0.37

580

Explicit bacterial Sepsis

421

0.69

1.22

1.0

4.90

5.38

u/ml

—

186

Other congenital malformations

771

1.24

1.22

1.1

5.76

6.97

u/ml

0.33

361

Other predominantly sexually transmitted diseases, not elsewhere classified

183

1578

1.16

1.22

1.1

3.80

5.07

u/ml

0.56

678

Testicular dysfunction

172

1.52

1.21

1.0

1.1

4.51

3.56

u/ml

0.14

Burns and corrosions confined to eye and internal organs

140

1.58

1.21

1.0

1.1

1.57

4.21

u/ml

1.24

Melanocytic naevi of other and unspecified parts of face

297

1.39

1.20

1.1

5.28

5.78

u/ml

0.05

121

Pyogenic arthritis

213

1.46

1.20

1.1

2.04

5.62

u/ml

1.32

Other diseases of peritoneum

148

1.56

1.20

1.0

1.1

1.51

3.14

u/ml

—

Autoimmune diseases

907

4933

0.93

1.20

1.1

5.75

5.54

u/ml

0.09

381

2156

Otitis externa, unspecified

674

1.25

1.20

1.1

4.72

4.89

u/ml

0.02

284

Hypertensive Heart Disease

348

0.70

1.20

1.0

0.67

2.70

u/ml

1.94

125

Other disorders of conjunctiva

383

1.33

1.19

1.0

1.1

3.12

2.93

u/ml

0.05

142

severe traumatic brain injury, does not include concussion

638

0.75

1.19

1.0

1.1

4.80

3.98

u/ml

0.16

262

Volume depletion

238

0.59

1.19

1.1

9.03

5.75

u/ml

—

100

Gingivitis and periodontal diseases

822

3950

1.07

1.18

1.1

4.23

5.11

u/ml

0.61

371

1622

Other skin changes

675

1.25

1.18

1.1

1.0

8.75

3.57

u/ml

0.91

277

Burn and corrosion confined to eye and adnexa

125

1.61

1.18

1.1

1.91

4.05

u/ml

—

Scleritis

1.95

1.18

1.0

1.1

6.01

6.31

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

533

1.28

1.18

1.0

1.1

1.67

3.49

u/ml

1.49

200

Diseases of inner ear

269

2308

1.13

1.17

1.0

1.1

3.35

3.81

u/ml

0.21

113

890

Other and unspecified local infections of skin and subcutaneous tissue

463

1.30

1.17

1.1

9.39

4.42

u/ml

0.78

186

Persistent delusional disorders

310

0.64

1.17

1.1

9.15

3.84

u/ml

—

122

Disorders of vitreous body

196

1645

1.15

1.17

1.0

1.1

2.23

3.39

u/ml

0.73

590

Tumor necrosis factor alpha inhibitors

101

1223

0.82

1.16

1.0

1.1

4.56

5.58

u/ml

0.27

506

Supervision of high-risk pregnancy

209

1440

0.87

1.16

1.1

5.53

6.73

u/ml

0.29

585

Other disorders starting during childhood or adolescence

716

1.24

1.16

1.1

10.05

9.10

u/ml

0.11

388

Other disorders of male genital organs

174

1.50

1.15

1.0

1.1

0.96

4.44

u/ml

2.51

Statin medication

541

3309

0.92

1.15

1.1

3.58

4.11

u/ml

0.32

216

1372

Hypertensive heart and/or renal disease

407

0.73

1.15

1.0

1.01

3.10

u/ml

1.76

150

Benign lipomatous neoplasm

148

1261

1.18

1.15

1.0

1.1

5.55

3.64

u/ml

0.43

494

Temporal arteritis

0.00

1.15

0.0

1.1

—

1.54

—

Localized swelling, mass and lump of skin and subcutaneous tissue

193

1679

1.15

1.1

4.32

4.51

u/ml

0.06

696

Fracture of shoulder and upper arm

160

1858

0.86

1.15

1.1

5.87

6.21

u/ml

0.06

807

Acute generalized exanthematous pustulosis

199

1.46

1.14

1.0

1.1

5.79

7.17

u/ml

0.18

Open wound of hip and thigh

191

1.48

1.14

1.0

1.1

2.47

5.15

u/ml

0.84

Focal epilepsy, mode (most common among epilepsy diagnosis)

1001

0.81

1.14

1.1

7.17

5.43

u/ml

0.23

437

Pregnancy, childbirth and the puerperium

197

1183

0.87

1.14

1.1

6.38

7.71

u/ml

0.34

533

Residual foreign body in soft tissue

258

1.40

1.13

1.0

1.1

3.34

5.01

u/ml

0.40

108

Graves ophthalmopathy

103

1.66

1.13

1.0

1.1

0.13

3.26

u/ml

—

Basal cell carcinoma, including avohilmo

114

941

0.83

1.13

1.1

2.09

2.96

u/ml

0.32

354

Viral infections of the central nervous system

422

1.31

1.13

1.1

4.90

4.16

u/ml

0.17

169

Cysts of oral region, not elsewhere classified

250

1.41

1.12

1.0

1.1

2.80

5.00

u/ml

0.62

106

Other/unspecified enthesopathies of lower limb, excluding foot

370

1.33

1.12

1.0

1.1

3.16

4.11

u/ml

0.22

144

Skin changes due to chronic exposure to nonionizing radiation

535

1.26

1.12

1.1

1.0

3.01

2.48

u/ml

0.10

211

Other local infections of skin and subcutaneous tissue

484

1.28

1.12

1.0

1.1

9.07

4.30

u/ml

0.77

194

Tooth agenesis EXCLUDE clefts and syndromes

432

1.31

1.12

1.1

7.67

u/ml

0.00

217

Retinal detachment with retinal break

327

1.35

1.12

1.0

1.1

7.72

3.03

u/ml

0.43

127

Endometriosis of ovary

125

1028

1.19

1.11

1.1

2.35

3.75

u/ml

1.01

420

Ischemic heart diseases

413

2724

0.91

1.11

1.1

2.71

4.62

u/ml

1.80

151

1091

Complications of medical and surgical care

483

4075

1.09

1.11

1.1

3.82

4.67

u/ml

0.53

212

1628

Fitting and adjustment of other devices

117

884

1.20

1.11

1.1

1.0

4.23

3.53

u/ml

0.09

327

Glucosamine medication

119

795

1.20

1.11

1.0

2.05

2.69

u/ml

0.34

281

Actinic keratosis

489

1.27

1.10

1.1

1.0

3.24

2.24

u/ml

0.19

194

Anogenital herpesviral [herpes simplex] infection

530

1.27

1.10

1.1

3.52

4.04

u/ml

0.12

212

Unspecified/other endometriosis

809

1.22

1.10

1.1

3.20

4.88

u/ml

0.70

343

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

724

1.23

1.10

1.1

10.05

7.88

u/ml

0.30

388

Other and unspecified injuries of wrist and hand

243

1.41

1.10

1.1

8.05

5.39

u/ml

0.27

104

Female infertility, tubal origin

320

1.35

1.09

1.1

1.19

3.41

u/ml

1.55

114

Pulmonary embolism

105

872

1.21

1.09

1.1

5.79

3.46

u/ml

0.34

332

Pulmonary heart disease

105

872

1.21

1.09

1.1

5.79

3.46

u/ml

0.34

332

Helminthiases

1.83

1.09

1.2

1.1

15.05

4.94

u/ml

—

Autoimmune hepatitis

2.40

1.09

1.0

1.1

—

3.18

—

Testicular hypofunction

152

1.52

1.09

1.0

1.1

4.30

3.11

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

355

2476

0.90

1.09

1.1

2.49

4.33

u/ml

2.60

140

974

Acute nasopharyngitis (common cold)

687

1.23

1.09

1.0

1.1

4.48

4.50

u/ml

0.00

279

Use of hypnotics and sedatives

727

4475

0.93

1.09

1.1

3.87

4.67

u/ml

0.58

299

1826

Infectious mononucleosis

110

920

1.20

1.09

1.1

5.43

7.12

u/ml

0.42

416

Effects of foreign body entering through natural orifice

179

1557

1.15

1.09

1.1

4.37

6.04

u/ml

0.77

695

Pilonidal cyst

728

0.78

1.08

1.1

15.02

4.88

u/ml

0.41

295

Viral pneumonia (known virus, not influenza)

1.70

1.08

1.1

4.08

7.38

u/ml

—

Other congenital malformations of the digestive system

362

1.33

1.08

1.1

8.06

8.87

u/ml

0.10

189

Other and unspecified nerve root and plexus disorders, also in other diseases

122

1030

1.19

1.08

1.0

1.1

4.31

3.34

u/ml

0.22

400

Allergic purpura

169

1.49

1.07

1.1

12.15

5.82

u/ml

—

Unspecified fall

329

2929

1.11

1.07

1.1

7.85

5.96

u/ml

0.70

164

1285

Guttate psoriasis

1.94

1.06

1.1

1.34

4.52

u/ml

—

Anisometropia and aniseikonia

153

1.51

1.06

1.0

1.1

5.35

9.28

u/ml

—

Periapical abscess

253

2833

0.89

1.05

1.0

1.1

6.48

4.79

u/ml

0.71

131

1152

Malignant neoplasm of rectum

192

0.57

1.05

1.2

1.1

4.04

2.97

u/ml

—

Familial hypercholesterolemia, with ischemic heart disease

113

1.60

1.05

1.0

3.07

2.06

u/ml

—

Sexual dysfunction

1.81

1.05

1.0

1.1

7.17

1.65

u/ml

—

Other female pelvic inflammatory diseases

104

868

1.20

1.05

1.1

1.44

3.80

u/ml

2.93

336

Long labour

271

2077

1.12

1.04

1.1

4.61

5.50

u/ml

0.28

116

830

Superficial injury of thorax

696

1.22

1.04

1.1

5.34

4.06

u/ml

0.31

275

Angina pectoris

146

1132

0.86

1.04

1.1

1.0

1.03

2.68

u/ml

3.19

407

Puerperal sepsis

651

1.23

1.04

1.1

1.0

2.34

3.25

u/ml

0.38

232

Tic and related disorders

130

1.56

1.04

1.1

1.66

7.85

u/ml

2.74

Tic and related disorders

130

1.56

1.04

1.1

1.66

8.77

u/ml

2.91

Single delivery by caesarean section

193

1263

0.87

1.04

1.1

4.84

6.15

u/ml

0.46

547

Other maternal disorders predominantly related to pregnancy

553

3206

1.08

1.04

1.1

5.35

5.47

u/ml

0.04

215

1300

Other disorders of optic disc

1.85

1.03

1.4

1.1

20.86

3.51

u/ml

—

Sicca syndrome [Sjögren]

332

1.33

1.03

1.0

1.1

1.59

4.34

u/ml

1.66

123

Systemic connective tissue disorders

184

1611

1.14

1.03

1.1

3.33

4.65

u/ml

0.54

639

Other malignant neoplasms of skin (=non-melanoma skin cancer)

113

919

0.84

1.03

1.1

1.0

3.21

2.77

u/ml

0.13

348

Other heart diseases, wide

738

4821

0.93

1.02

1.1

4.12

5.39

u/ml

1.09

323

2027

Divergent concomitant strabismus

462

0.73

1.02

1.0

1.1

3.76

3.97

u/ml

0.03

183

Emotional disorders starting during childhood or adolecense, excluding more controls

567

1.25

1.02

1.1

5.70

7.26

u/ml

0.30

303

Digestive system disorders of fetus and newborn

0.00

1.02

0.0

1.2

—

7.43

—

Other and unspecified injuries of lower leg

483

1.27

1.01

1.1

13.13

5.60

u/ml

0.34

208

Postpartum haemorrhage due to anatomy

127

1084

1.18

1.01

1.1

5.51

4.53

u/ml

0.20

443

Inflammatory disease of cervix uteri

230

1.40

1.01

1.1

0.85

2.57

u/ml

1.36

Excessive earwax

289

2540

1.11

1.01

1.1

4.85

5.22

u/ml

0.13

131

1066

Lesion of plantar nerve

188

1.44

1.01

1.1

1.12

3.66

u/ml

1.29

Septal defects

562

0.76

1.01

1.0

1.1

9.14

8.49

u/ml

0.08

290

Disorders of vitreous body and globe

201

1702

1.14

1.01

1.0

1.1

2.38

3.42

u/ml

0.64

625

Premature rupture of membranes

274

1759

1.12

1.01

1.1

3.91

5.60

u/ml

0.76

100

735

Heart failure and bmi 25plus

586

0.81

1.00

1.1

1.0

4.65

2.64

u/ml

0.24

220

Event of undetermined intent

413

1.29

1.00

1.1

8.60

5.67

u/ml

0.27

174

Vascular disorders of the intestines

1.65

1.00

1.1

0.06

2.38

u/ml

—

Fracture of lumbar spine and pelvis

663

0.78

1.00

1.1

4.71

3.76

u/ml

0.15

262

Astigmatism

448

1.28

1.00

1.1

5.01

7.90

u/ml

0.74

228

Falls/tendency to fall

1023

4840

1.06

0.99

1.1

5.59

5.25

u/ml

0.17

469

2033

Severe mental retardation

0.00

0.99

0.0

1.2

—

7.03

—

Disorders of lens

253

1765

0.89

0.99

1.0

1.1

5.65

3.16

u/ml

1.01

113

648

Other sexually transmitted chlamydial diseases

139

1198

1.16

0.99

1.1

7.62

7.22

u/ml

0.08

560

Nontoxic goitre/thyroid nodule

129

1104

1.17

0.99

1.0

1.1

2.73

3.16

u/ml

0.10

421

Lung diseases due to external agents

317

1.33

0.99

1.1

1.65

4.09

u/ml

1.68

128

Problems related to lifestyle

729

0.79

0.99

1.0

1.1

5.15

5.64

u/ml

0.07

302

Parkinson's disease, excluding more controls

189

0.60

0.99

1.0

0.40

1.18

u/ml

—

Brain glioblastoma

0.00

0.98

0.0

1.0

—

5.40

—

Anoxic brain damage

0.00

0.98

0.0

1.1

—

3.00

—

Medical abortion

558

2806

1.08

0.98

1.1

5.36

5.44

u/ml

0.03

228

1138

Exclusions for E4_PCOS_BROAD

136

1170

1.16

0.98

1.1

3.98

5.39

u/ml

0.48

517

Leukaemia of unspecified cell type

0.00

0.97

0.0

1.0

—

4.47

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

130

1028

0.86

0.97

1.1

1.0

3.09

2.83

u/ml

0.08

384

Disorders of eyelid in diseases classified elsewhere

132

1.52

0.97

1.3

1.1

14.19

4.42

u/ml

0.61

Procreative management

340

2581

1.10

0.97

1.1

5.82

6.65

u/ml

0.31

176

1163

Benign neoplasm: Other and unspecified parts of mouth

100

1.61

0.97

1.0

2.38

2.57

u/ml

—

Other and unspecified follicular disorders

207

1.41

0.97

1.1

1.0

2.75

3.90

u/ml

0.28

Reactive arthropathies

433

1.27

0.96

1.0

1.1

3.78

4.71

u/ml

0.19

157

Contact with machinery

398

1.28

0.96

1.1

3.58

4.70

u/ml

0.27

156

149

1.49

0.96

1.1

30.73

2.94

u/ml

0.65

Other sleep disorders

532

1.24

0.95

1.1

3.36

4.27

u/ml

0.23

211

Adalimumab

714

0.80

0.95

1.1

5.15

4.72

u/ml

0.07

291

Alcoholic gastritis

0.00

0.95

0.0

1.0

—

3.12

—

Other protozoal intestinal diseases

117

1.55

0.94

1.1

9.08

4.44

u/ml

0.46

Benign neoplasm: Transverse colon

225

1.38

0.94

1.1

1.0

0.67

2.89

u/ml

1.77

Other diseases of anus and rectum

139

1200

1.16

0.94

1.1

6.26

3.89

u/ml

0.47

486

Other and unspecified mononeuropathies, also in other diseases

1.62

0.94

1.1

1.0

18.10

3.01

u/ml

—

Obsessive-compulsive disorder

688

1.21

0.94

1.0

1.1

6.99

5.98

u/ml

0.13

304

Cardiomyopathy (excluding other)

363

0.71

0.93

1.1

1.0

9.95

4.56

u/ml

—

144

Other gastritis (incl. Duodenitis)

733

1.20

0.93

1.1

2.67

3.45

u/ml

0.31

280

Polyneuropathies and other disorders of the peripheral nervous system

642

1.22

0.93

1.1

4.79

3.90

u/ml

0.18

255

Intestinal adhesions without obstruction

217

1.39

0.93

1.0

1.1

4.82

2.53

u/ml

0.23

Cramp and spasm

226

1.38

0.92

1.1

7.68

4.84

u/ml

0.23

Maternal care for other conditions predominantly related to pregnancy

245

2160

1.11

0.92

1.1

3.19

5.28

u/ml

1.00

884

Delayed puberty

1.66

0.92

1.1

18.59

9.09

u/ml

—

Neuralgia and neuritis, unspecified

209

1.39

0.92

1.0

1.1

4.08

3.83

u/ml

0.03

Other congenital malformations of tongue, mouth and pharynx

175

1.44

0.92

1.1

9.17

u/ml

0.00

110

Parkinson's disease, strict definition

184

0.60

0.92

1.0

0.29

1.84

u/ml

—

Pain associated with micturition

535

1.24

0.92

1.0

1.1

10.06

5.00

u/ml

0.74

227

Coxarthrosis

171

1284

0.88

0.92

1.1

1.0

1.57

3.20

u/ml

2.06

449

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

314

2827

1.10

0.91

1.1

5.77

6.00

u/ml

0.05

154

1260

Osteoporosis

550

1.22

0.91

1.1

5.24

3.50

u/ml

0.29

220

Bacterial pneumonia (organism specified)

218

1765

1.12

0.91

1.1

3.89

5.04

u/ml

0.58

120

706

Coeliac disease

717

1.20

0.91

1.1

7.41

5.15

u/ml

0.39

305

Cardiac arrhythmias

525

3667

0.93

0.91

1.1

4.00

5.16

u/ml

0.76

225

1528

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cat dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS